Major League Football (MLFB) 10-Q 17 Mar 17 2017 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Jan. 31, 2017	Mar. 15, 2017
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jan. 31, 2017
Entity Registrant Name	MAJOR LEAGUE FOOTBALL INC
Entity Central Index Key	1,308,569
Current Fiscal Year End Date	--04-30
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2,017
Entity Filer Category	Smaller Reporting Company
Entity Units Outstanding		54,734,301
Trading Symbol	MFLB
Entity Current Reporting Status	Yes

BALANCE SHEETS

BALANCE SHEETS - USD ($)	Jan. 31, 2017	Apr. 30, 2016
CURRENT ASSETS
Cash	$ 24,118	$ 3,799
Equipment deposit	260,323	260,323
Prepaid legal	7,500
Prepaid consulting	11,094	650,853
TOTAL CURRENT ASSETS	303,035	914,975
Furniture, fixtures and equipment, net	2,610	2,958
OTHER ASSETS
Rent deposit	11,918	11,918
TOTAL OTHER ASSETS	11,918	11,918
TOTAL ASSETS	317,563	929,851
CURRENT LIABILITIES
Accounts payable	1,008,299	736,411
Accounts payable - related parties	6,646
Accrued officer compensation	1,635,000	960,000
Accrued expenses	179,481	212,287
Advances	61,000
State income taxes payable	110,154	110,154
Convertible unsecured promissory note, net of $6,574 debt discount	43,426	18,220
Convertible secured promissory note, net of $55,754 debt discount	299,246	78,356
Derivative liability	596,602	462,531
Notes payable	300,000	100,000
Notes payable, related parties	15,300	20,300
Accrued officer payroll taxes	91,039	50,841
Accrued interest	63,347	8,763
TOTAL CURRENT LIABILITIES	4,409,540	2,757,863
COMMITMENTS AND CONTINGENCIES (NOTE 6)
STOCKHOLDERS' DEFICIENCY
Preferred Stock, $0.001 par value, 50,000,000 shares authorized; Series A designated 7,500,000 shares and remainder undesignated; No shares issued and outstanding at January 31, 2017 and April 30, 2016, respectively
Common stock, $0.001 par value, 150,000,000 shares authorized; 48,967,203 and 41,013,077 shares issued and outstanding at January 31, 2017 and April 30, 2016	48,967	41,013
Additional paid-in capital	21,367,464	19,252,807
Accumulated deficiency	(25,508,408)	(21,121,832)
TOTAL STOCKHOLDERS' DEFICIENCY	(4,091,977)	(1,828,012)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	$ 317,563	$ 929,851

BALANCE SHEETS (Parenthetical)

BALANCE SHEETS (Parenthetical) - USD ($)	Jan. 31, 2017	Apr. 30, 2016
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares authorized	50,000,000	50,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	150,000,000	150,000,000
Common stock, shares issued	48,967,203	41,013,077
Common stock, shares outstanding	48,967,203	41,013,077
Unsecured promissory notes [Member]
Debt discount	$ 6,574
Secured promissory notes [Member]
Debt discount	$ 55,754
Series A Preferred Stock [Member]
Preferred stock, shares authorized	7,500,000	7,500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0

STATEMENTS OF OPERATIONS

STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended		9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016
Revenue
League tryout camp fees		$ 63,195		$ 87,445
Total revenue		63,195		87,445
Operating Expenses
Salaries and wages	234,452	303,279	1,409,913	1,397,889
League tryout camp expense		80,858	11,325	131,248
Professional fees	110,120	593,750	1,718,750	1,027,006
Insurance	7,578	13,209	9,281	24,843
General and administrative	151,454	304,311	443,542	515,193
Total Operating Expenses	503,604	1,295,407	3,592,811	3,096,179
Operating Loss	(503,604)	(1,232,212)	(3,592,811)	(3,008,734)
Other Income (Expense)
Tax penalties and interest	(4,275)	(4,028)	(12,650)	(12,850)
Gain on settlement of unpaid taxes				84,580
Other income				3,500
Interest expense	(165,953)	(571)	(495,680)	(1,053,348)
Change in fair value of an embedded conversion option	(351,196)		(285,435)
Total Other Income (Expense)	(521,424)	(4,599)	(793,765)	(978,118)
Net Loss	$ (1,025,028)	$ (1,236,811)	$ (4,386,576)	$ (3,986,852)
Basic and Diluted Net Loss Per Share	$ (0.02)	$ (0.03)	$ (0.10)	$ (0.11)
Weighted Average Shares - Basic and Diluted	47,442,045	37,630,336	44,880,110	34,714,755

STATEMENTS OF CASH FLOWS

STATEMENTS OF CASH FLOWS - USD ($)	9 Months Ended
	Jan. 31, 2017	Jan. 31, 2016
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (4,386,576)	$ (3,986,852)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation expense	348	181
Amortization of prepaid consulting over service period	639,864	563,392
Issuance of common stock to employees for services	72,002
Issuance of common stock for consulting services		64,000
Cancellation of common stock issued erroneously for services		(3,500)
Amortization of common stock issued for employee services over vesting period	138,494	66,165
Amortization of stock options issued for employee services over vesting period	709,121	537,805
Amortization of stock options issued for consulting services over service period		253,919
Revaluation of stock options issued for consulting services over service period	(87,256)
Issuance of stock warrants for consulting services	828,549
Amortization of debt discount on convertible secured promissory note	415,890
Amortization of debt discount on convertible unsecured promissory note	25,206
Change in fair value of embedded conversion derivative	285,435
Write off debt discount on conversion of notes payable		1,037,561
Issuance of common stock to consultant for resolution of warrant exercise price	41,337
Changes in operating assets and liabilities:
Prepaid legal	(7,500)
Prepaid consulting	(105)	935
Rent deposit		(11,918)
Accounts payable	271,888	156,171
Accounts payable - related parties	6,646	540,000
Accrued officer compensation	675,000
Accrued expenses	(19,806)	(79,926)
Accrued officer payroll taxes	40,198	48,231
Advances	61,000
Accrued interest	54,584	10,788
Net cash used in operating activities	(235,681)	(803,048)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property and equipment		(3,255)
Net cash provided by (used in) investing activities		(3,255)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of convertible unsecured promissory notes		214,700
Proceeds from issuance of note payable	225,000	100,000
Proceeds from issuance of common stock	61,000	469,450
Proceeds from issuance of notes payable - related parties		21,300
Proceeds from exercise of stock warrants		1,000
Proceeds from exercise of stock options		3,000
Repayment of notes payable	(25,000)
Repayment of notes payable to related parties	(5,000)	(15,000)
Net cash provided by financing activities	256,000	794,450
NET INCREASE (DECREASE) IN CASH	20,319	(11,853)
CASH - BEGINNING OF PERIOD	3,799	29,583
CASH - END OF PERIOD	24,118	17,730
SUPPLEMENTAL DISCLOSURE OF CASH FLOWS
CASH PAID FOR INCOME TAXES		6,170
CASH PAID FOR INTEREST		5,000
NON-CASH INVESTING AND FINANCING ACTIVITIES
Issuance of common stock warrant for prepaid consulting fees		1,359,772
Exercise of common stock warrant for consulting services	13,000
Conversion of convertible unsecured promissory notes and accrued interest		699,098
Conversion of convertible secured promissory notes	195,000
Repayment of note payable by officer on behalf of Company		20,000
Change in embedded derivative liability for partial conversion of convertible secured promissory note	151,364
Issuance of common stock to employees previously unvested reclassified to additional paid in capital	$ 3,750

NATURE OF OPERATIONS, BASIS OF

NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Jan. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES	NOTE 1- NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Major League Football, Inc. (the “Company,” “we,” “our” or “us”) is seeking to establish, develop and operate Major League Football ("MLFB") as a professional spring football league. We launched a “Development Season” for 2016 but we still lack the adequate funding, and time, to launch a full season of professional, spring-league football during 2017; however, we intend to launch a “short” season that we believe will provide our league with recognition and demonstrate our economic model and the market’s desire for spring football. MLFB will serve as a pipeline to develop players on and off the field, coaches, officials, scouts, trainers and all other areas of the game that the National Football League (NFL) needs today. We will also give NFL representatives the opportunity to view our team practices, game footage, practice tapes and confer with league coaches, team officials and staff. On July 14, 2014, our Company entered into and closed a definitive Asset Purchase Agreement with Major League Football, LLC, a company formed in 2009, to establish, develop and operate a professional spring/summer football league to be known as “Major League Football” (“MLFB”). Pursuant to the terms of the Asset Purchase Agreement, we issued Major League Football, LLC 8,000,000 shares of our common stock in exchange for assets of Major League Football, LLC primarily comprised of business plans and related proprietary documents, trademarks and other related intellectual property related to the development of the league. Also, our Board of Directors was expanded, a new management team was appointed, and a number of league consultants were retained by our Company. On November 24, 2014, we changed our name to Major League Football, Inc. from Universal Capital Management, Inc. Prior to July 13, 2014, our primary business was to identify and advise in development and market consumer products. Our strategy employed three primary channels: Direct Response Television (Infomercials), Television Shopping Networks and Retail Outlets. We sought to assist and enable entrepreneurs to introduce products to the consumer market. Entrepreneurs could leverage our experience and valuable business contacts in functions such as product selection, marketing development, media buying and direct response television production. Inventors and entrepreneurs submitted products or business concepts for our input and advice. We generated revenues from two primary sources (i) management of the entire business cycle of the consumer product and (ii) sales of consumer products, for which we received a share of net profits of consumer products sold. Unless the context otherwise requires, all references to the “Company,” “we,” “our” or “us” and other similar terms collectively means Major League Football, Inc., a Delaware corporation. Our principal offices are presently located at 6230 University Parkway, Suite 301, Lakewood Ranch, Florida, 34240. Our telephone number is (774) 213-1995. Our internet website is located at: www.mlfb.com Going Concern The accompanying unaudited financial statements have been prepared assuming the Company will continue as a going concern. As reflected in the accompanying unaudited financial statements, the Company had no revenues, and a net loss and negative cash from operating activities of $4,386,576 and $235,861 respectively, for the nine months ended January 31, 2017. Additionally, at January 31, 2017, the Company has a working capital deficit of $4,106,505, an accumulated deficiency of $25,508,408 and a stockholders' deficiency of $4,091,977, which could have a material impact on the Company's financial condition and operations. In view of these matters, recoverability of any asset amounts shown in the accompanying unaudited financial statements is dependent upon the Company’s ability to achieve a level of profitability. These matters raise substantial doubt about the Company’s ability to continue as a going concern. Since inception, the Company has financed its activities from the sale of equity securities and from loans. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities and convertible debt securities, until such time that funds provided by operations, if ever, are sufficient to fund working capital requirements. The financial statements do not include any adjustments relating to the recoverability or classification of recorded assets and liabilities that might result should the Company be unable to continue as a going concern. Basis of Presentation The accompanying unaudited interim period financial statements of the Company are unaudited pursuant to certain rules and regulations of the Securities and Exchange Commission and include, in the opinion of management, all adjustments (consisting of only normal recurring accruals) necessary for a fair statement of the results of the periods indicated. Such results, however, are not necessarily indicative of results that may be expected for the full year. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. The accompanying unaudited financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended April 30, 2016, as filed with the Securities and Exchange Commission on July 29, 2016. The interim operating results for the nine months ending January 31, 2017 are not necessarily indicative of operating results expected for the full year. SIGNIFICANT ACCOUNTING POLICIES Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results could differ from the estimates. Significant estimates in the accompanying financial statements include the allowance for doubtful receivables, valuation of collateral on certain receivables, valuation of derivative liabilities, valuation of beneficial conversion features in convertible debt, valuation of equity based instruments issued for other than cash, valuation allowance on deferred tax assets, depreciable lives and estimated residual value of furniture, fixtures and equipment. Cash and Cash Equivalents For the statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at January 31, 2017 and 2016. Concentration of Credit Risk Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash. At January 31, 2017 and 2016 the Company did not have deposits with a financial institution that exceeded the FDIC deposit insurance coverage and determined that it had no cash equivalents. Furniture, Fixtures and Equipment Furniture, fixtures and equipment are stated at cost, net of accumulated depreciation. For financial accounting purposes, depreciation is generally computed by the straight-line method over the following useful lives: Furniture and fixtures 5 to 7 years Computer and office equipment 3 to 7 years For the nine months ended January 31, 2017 and 2016, the Company recorded $348 and $181 of depreciation expense, respectively and at January 31, 2017, the accumulated depreciation balance was $13,940. Provision for Loan Receivable and Collateral Deposit In March 2016, the Company loaned $125,000 to a third party so that the third party could make an investment that was expected to provide an additional return to the Company. Due to significant uncertainties regarding the collectability of the original principal amount and/or any additional return, the Company recorded an allowance for the full amount of the Loan Receivable and classified as Provision for Loan Receivable in the accompanying unaudited financial statements. In April 2016, the Company disbursed $50,000 of cash related to a collateral deposit with a third party that required additional deposits before a proposed transaction could be consummated. At April 30, 2016, no further deposits had been made and the Company recorded an allowance for the full amount of the Collateral Deposit and classified as Provision for Collateral Deposit in the accompanying unaudited financial statements. Convertible Promissory Notes Containing Embedded Derivatives We account for the embedded conversion option contained in convertible instruments under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”. The embedded conversion option contained in certain convertible instruments are bifurcated and accounted for as derivative liabilities at the date of issuance and are adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option liabilities was determined using the Black Scholes Pricing model. On the initial measurement date, the fair value of the embedded conversion option liability was recorded as a derivative liability and was allocated as debt discount up to the proceeds of the notes with the remainder charged to current period operations as initial derivative expense. Gains and losses derived from changes in the fair value of the derivative liability were recorded as a component of other income (expense) in the accompanying statements of operations. Upon conversion of debt, the fair value of the derivative is reclassified into equity and the common stock is recorded at book value of the debt. Fair Value of Financial Instruments ASC 820, Fair Value Measurements and Disclosures, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, amounts receivable, accounts payable, unsecured convertible notes payable, secured convertible notes payable, notes payable, notes payable – related party and an embedded conversion option liability. Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments, the Company believes that the recorded values of the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. Assets and liabilities measured at fair value on a recurring/non-recurring basis consist of the following at January 31, 2017: Carrying Value Fair Value Measurements at At January 31, 2017 January 31, 2017 Level 1 Level 2 Level 3 Embedded conversion option liability $ 596,602 $ — $ — $ 596,602 The following is a summary of activity of Level 3 assets and liabilities for the nine months ended January 31, 2017: Embedded Conversion Option Liability Balance – April 30, 2016 $ 462,531 Loss from change in the fair value of derivative liabilities 285,435 Change in embedded derivative liability for partial conversions of a convertible secured promissory note (151,364 ) Balance – January 31, 2017 $ 596,602 Changes in fair value of the embedded conversion option liability are included in other income (expense) in the accompanying unaudited financial statements. Revenue Recognition League Tryout Camps The Company recognizes league tryout camp revenue on the dates that the tryout camps were held. There were no tryout camps held by the Company during the nine months ended January 31, 2017. Football League Operations The Company will recognize revenue from future football league operations including gate, parking and concessions, stadium advertising and merchandising, licensing fees, sponsorships, naming rights, broadcast and cable, franchise fees, social media and on-line digital media including merchandising, advertising and subscriptions. Since the football operations have not commenced, there was no revenue from football league operations during the nine months ended January 31, 2017. Stock Based Compensation Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. Pursuant to ASC 505-50, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the service period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date. Income Taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the asset or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or noncurrent depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce the deferred tax assets to the amount expected to be realized. The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a “more-likely-than-not” threshold. At January 31, 2017 and 2016, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements. Net Loss per Share of Common Stock The Company computes net earnings (loss) per share in accordance with ASC 260-10, “Earnings per Share.” ASC 260-10 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period. The Company’s diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. At January 31, 2017, there were options to purchase 7,690,000 shares of the Company’s common stock, 10,298,746 warrants to purchase shares of the Company's common stock, 166,667 shares of the Company’s common stock reserved for issuance related to convertible unsecured notes payable and 6,748,354 shares of the Company’s common stock reserved for issuance related to convertible secured notes payable which may dilute future earnings per share. Related Parties Parties are considered related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions are recorded at fair value of the goods or services exchanged. New Accounting Pronouncements In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements­ Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern (ASU 2014-15). The guidance in ASU 2014-15 sets forth management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern as well as required disclosures. ASU 2014-15 indicates that, when preparing financial statements for interim and annual financial statements, management should evaluate whether conditions or events, in the aggregate, raise substantial doubt about the entity's ability to continue as a going concern for one year from the date the financial statements are issued or are available to be issued. This evaluation should include consideration of conditions and events that are either known or are reasonably knowable at the date the financial statements are issued or are available to be issued, as well as whether it is probable that management's plans to address the substantial doubt will be implemented and, if so, whether it is probable that the plans will alleviate the substantial doubt. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods and annual periods thereafter. Early application is permitted. The adoption of this guidance is not expected to have a material impact on the Company's unaudited financial statements. The Company has evaluated other recent accounting pronouncements and their adoption, and has not had, and is not expected to have, a material impact on the Company's financial position or results of operations. Other new pronouncements issued but not yet effective until after January 31, 2017 are not expected to have a significant effect on the Company's financial position or results of operations.

DEBT

DEBT	9 Months Ended
	Jan. 31, 2017
Debt Disclosure [Abstract]
DEBT	NOTE 2 – DEBT January 31, 2017 April 30, 2016 Notes Payable: Note payable – January 6, 2016. Interest at 8% and principal payable on demand. $ 100,000 $ 100,000 Note payable – June 6, 2016. Interest at 4% and principal payable on demand. 10,000 — Note payable – August 4, 2016. Interest at 8% and principal payable on demand. 105,000 — Note payable – September 27, 2016. Interest at 4% and principal payable on demand. 30,000 — Note payable – September 29, 2016. Interest at 4% and principal payable on demand. 5,000 — Note payable – September 29, 2016. Interest at 4% and principal payable on demand. 30,000 — Note payable – October 3, 2016. Interest at 4% and principal payable on demand. 20,000 — Total Notes payable $ 300,000 $ 100,000 On January 6, 2016, the Company received $100,000 of proceeds from the issuance of a promissory note and recorded as Note Payable. The terms of the promissory note include interest accrued at 8% annually and the principal and interest payable on demand. Through January 31, 2017, the Company has accrued $6,709 of interest related to the promissory note and included in accrued interest in the accompanying unaudited financial statements. On June 6, 2016, the Company received $10,000 of proceeds from the issuance of a promissory note and recorded as Note Payable. The terms of the promissory note include interest accrued at 4% annually and the principal and interest payable on demand. Through January 31, 2017, the Company has accrued $263 of interest related to the promissory note and included in accrued interest in the accompanying unaudited financial statements. On August 4, 2016, the Company received $130,000 of proceeds from the issuance of a promissory note and recorded as Note Payable. The terms of the promissory note include interest accrued at 8% annually and the principal and interest payable on demand. On January 26, 2017, the Company repaid $25,000 of the promissory note principal resulting in an outstanding principal balance of $105,000 at January 31, 2017. See Note 7 – Subsequent Events. Through January 31, 2017, the Company has accrued $5,124 of interest related to the promissory note and included in accrued interest in the accompanying unaudited financial statements. On September 27, 2016, the Company received $30,000 of proceeds from the issuance of a promissory note and recorded as Note Payable. The terms of the promissory note include interest accrued at 4% annually and the principal and interest payable on demand. Through January 31, 2017, the Company has accrued $418 of interest related to the promissory note and included in accrued interest in the accompanying unaudited financial statements. On September 29, 2016, the Company received $5,000 of proceeds from the issuance of a promissory note and recorded as Note Payable. The terms of the promissory note include interest accrued at 4% annually and the principal and interest payable on demand. Through January 31, 2017, the Company has accrued $68 of interest related to the promissory note and included in accrued interest in the accompanying unaudited financial statements. On September 29, 2016, the Company received $30,000 of proceeds from the issuance of a promissory note and recorded as Note Payable. The terms of the promissory note include interest accrued at 4% annually and the principal and interest payable on demand. Through January 31, 2017, the Company has accrued $411 of interest related to the promissory note and included in accrued interest in the accompanying unaudited financial statements. On October 3, 2016, the Company received $20,000 of proceeds from the issuance of a promissory note and recorded as Note Payable. The terms of the promissory note include interest accrued at 4% annually and the principal and interest payable on demand. Through January 31, 2017, the Company has accrued $263 of interest related to the promissory note and included in accrued interest in the accompanying unaudited financial statements. January 31, 2017 April 30, 2016 Notes Payable, Related Party: Notes payable, related party. Seven (7) separate loans beginning on February 11, 2015 with last loan on August 28, 2015. No interest and principal payable on demand. $ 15,300 $ 20,300 Total Notes payable, related party $ 15,300 $ 20,300 From February to July 2015, an officer of the Company provided $15,300 of funds for working capital requirements. There is no formal agreement and no interest is being accrued by the Company with the principal due on demand. During the three months ending October 31, 2015, the Company repaid $15,000 of these funds leaving a balance outstanding of $300. Effective August 28, 2015, the officer personally repaid $20,000 of notes payable for the Company resulting in a balance outstanding of $20,300. During the three months ending January 31, 2017, the Company repaid $5,000 of these funds and the outstanding balance owed to the officer was $15,300 at January 31, 2017, recorded as Notes Payable – Related Parties in the accompanying unaudited financial statements. See Note 5 – Related Party Transactions and Note 7 – Subsequent Events. January 31, 2017 April 30, 2016 Convertible Unsecured Note Payable: Unsecured convertible promissory note payable – Interest accrued at 5% and principal and interest due 12 months from the issuance date. 50,000 50,000 Less: Debt discount (6,574 ) (31,780 ) Total Convertible Unsecured Note Payable, net of debt discount $ 43,426 $ 18,220 On April 14, 2016, the Company received $50,000 of proceeds from the issuance of an unsecured convertible promissory note for working capital purposes. The terms include interest accrued at 5% annually and the principal and interest payable in one year on April 14, 2017. The note holder at its sole discretion, has the right to convert the principal amount, along with all accrued interest, into shares of the Company’s common stock at the conversion price of $0.30 per share. Through January 31, 2017, the Company accrued $2,006 of interest related to the unsecured convertible promissory note and included in accrued interest in the accompanying financial statements. In accordance with ASC 470-20, the Company determined that a beneficial conversion feature (BCF) existed and utilizing the Black-Scholes Pricing Model, determined that the BCF fair value was $33,333 and recorded the $33,333 BCF as a debt discount with an offset to additional paid in capital. The initial $33,333 BCF assumed that 166,667 shares would be issued upon conversion of the promissory note. The debt discount is being amortized as additional interest expense ratably over the one-year term of the note and during the nine months ended January 31, 2017, the Company recorded $25,206 of interest expense with a corresponding reduction to the debt discount. The debt discount has a balance of $43,426 at January 31, 2017. The Company used the following assumptions in the calculation: Stock Price (issue date) $ 0.50 Conversion Price $ 0.30 Expected Remaining Term 1 year Volatility 247 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.22 % January 31, 2017 April 30, 2016 Convertible Secured Note Payable: Secured convertible promissory note payable – issued March 9, 2016 - Interest accrued at 10% and principal and interest due one year from the issuance date. $ 550,000 $ 550,000 Less: conversion of $195,000 of principal to common stock (195,000 ) — Less: debt discount (55,754 ) (471,644 ) Total Convertible Secured Notes Payable, net of debt discount $ 299,246 $ 78,356 On March 9, 2016 (“Effective Date”), the Company received $445,000 of net proceeds for working capital purposes from the issuance of a $550,000 face value convertible secured promissory note net of an original issue discount of $50,000 and debt issue costs paid to or on behalf of the lender of $55,000. The terms include interest accrued at 10% annually and the principal and interest payable is payable in one year on March 9, 2017. See Note 7 – Subsequent Events. Any amount of the principal or interest on this Note which is not paid when due shall bear Interest at the rate of the lower of Twenty-Two Percent (22%) per annum, or the highest rate permitted by law, from the due date thereof until the same is paid. Through January 31, 2017, 2017, $48,084 of accrued interest was recorded in the accompanying unaudited financial statements. The lender has the right at any time after the effective date, at its election, to convert all or part of the outstanding and unpaid principal sum and accrued interest into shares of common stock of the Company, subject to certain conversion limitations set forth in the promissory note and certain price protection described below, as per the conversion formula: Number of shares receivable upon conversion equals the dollar conversion amount divided by the Conversion Price. The Conversion Price is equal to seventy percent (70%) of the average of the lowest three VWAPs of the Common Stock during the twenty (20) Trading Days immediately preceding a Conversion Date. The promissory note contains customary affirmative and negative covenants of the Company. The Conversion Price is subject to “full ratchet” and other customary anti-dilution protections. In relation to the convertible secured promissory note, the Company issued the lender two warrants, a Series A warrant with a three (3) year term to acquire 250,000 shares of common stock of the Company at an exercise price of $1.02 per share and a Series B warrant with a three (3) year term to acquire 250,000 shares of common stock of the Company at an exercise price of $1.19 per share. The principal amount of the promissory note, initially $550,000, may be prepaid in full solely during the dates set forth below, which shall be subject to the following upward adjustments, subject to the payment period upon which the date all amounts hereunder are paid in full by the Borrower occurs, as follows: Date of Note Satisfaction Principal Amount of this Note 0 to 30 days after the OID $ 605,000 31 to 60 days after the OID $ 632,500 61 to 90 days after the OID $ 660,000 91 - 120 days after the OID $ 687,500 Subsequent to 120 days after the Issue Date, the Company has no right or option to prepay the principal amount of the promissory note. As of July 9, 2016, the Company did not prepay the principal and this option is no longer available. As collateral security, the promissory note is secured by all collateral granted by an officer of the Company to the Holder, including but not limited to two million (2,000,000) shares of Common Stock, in accordance with the terms and conditions of a Pledge Agreement by and between the officer and the lender, dated as of the OID. The Company evaluated the secured convertible promissory note and the related warrants in accordance with ASC 815 “ Derivatives and Hedging Derivatives and Hedging The Company evaluated the warrants and determined that there was no derivative treatment required as the warrants contained a fixed exercise price with an adjustment only based upon customary items including stock dividends and splits, subsequent rights offerings and pro rate distributions. The Company calculated the relative fair value between the note and the warrants on the issue date utilizing the Black Scholes Pricing Model for the warrants. As a result, the Company allocated $239,069 to the warrants which was recorded as a debt discount with an offset to additional paid in capital in the unaudited financial statements. The warrant calculation used the following assumptions; stock price $0.93, Class A warrant exercise price $1.02, Class B warrant exercise $1.19, expected term of 3 years, expected volatility of 287% and discount rate of 0.30%. On the note issue date of March 9, 2016, the Company recorded the following debt discounts as offsets to the $550,000 note payable which will be amortized over the one-year term of the note: (1) OID of $50,000, (2) debt issue costs of $55,000, (3) warrant relative fair value of $239,069 and (4) embedded conversion option liability of $205,931. As a result, the Company recorded a $723,646 expense for the initial fair value of embedded conversion derivative, recorded as a separate item in other income (expense) in the accompanying financial statements. The Company performed a revaluation of the embedded conversion liability using the Black Scholes Pricing Model at April 30, 2016 that resulted in a calculated value of $462,531. On (1) September 13, 2016, (2) September 30, 2016 and (3) October 26, 2016, the lender elected to exercise their right to convert $15,000 on each of the above dates or a total conversion amount of $45,000 of the principal balance and the note payable balance was $505,000 at October 31, 2016 (See Note 4 – Common Stock). The Company performed a revaluation of the embedded conversion liability using the Black Scholes Pricing Model on each of the three conversion dates that resulted in a calculated embedded conversion liability value of (1) $544,400, (2) $410,038 and (3) $385,429. The Company recorded a total expense of $139,642 for the change in the fair value of compound embedded derivative, recorded to other income (expense) in the unaudited financial statements. Additionally, the Company reclassified$38,540 of embedded conversion option liability to additional paid in capital for the change in the fair value of compound embedded derivative related to the share conversion on the respective dates. For the three conversion dates of 1) September 13, 2016, (2) September 30, 2016 and (3) October 26, 2017, the revaluation of the embedded conversion liability was calculated using the Black Scholes Pricing Model with the following assumptions; stock price (1) $0.29, (2) $0.24 and (3) $0.22, conversion price (1) $0.18, (2) 0.17 and (3) $0.15, expected term of (1) 0.48 years (2) 0.44 years and (3) 0.37 years, expected volatility of (1) 181%, (2) 175% and (3) 179% and discount rate of (1) 0.25%, (2) 0.20% and (3) 0.25%. The change in the derivative liability assumed that (1) 3,142,857, (2) 3,240,318 and (3) 3,496,593 shares would be issued upon conversion of the promissory note. The Company performed a revaluation of the embedded conversion liability using the Black Scholes Pricing Model at October 31, 2016 that resulted in a calculated value of $358,230. The Company recorded $27,299 of income for the change between October 26, 2016 and October 31, 2016 in the fair value of compound embedded derivative, recorded as a separate item in other income (expense) in the accompanying unaudited financial statements. The revaluation of the embedded conversion liability at October 31, 2016 was calculated using the Black Scholes option pricing model with the following assumptions; stock price $0.20, conversion price $0.14, expected term of 0.35 years, expected volatility of 175% and discount rate of 0.20%. The change in the derivative liability assumed that 3,567,177 shares would be issued upon conversion of the promissory note at October 31, 2016. On (1) November 2, 2016, (2) November 15, 2016, (3) December 13, 2016, (4) December 16, 2016, (5) December 23, 2016, (6) December 29, 2016, (7) January 6, 2017, (8) January 12, 2017, (9) January 23, 2017 and (10) January 24, 2017, the lender elected to exercise their right to convert on each of the above dates for an aggregate total conversion amount of $150,000 of the principal balance and the note payable balance is $355,000 at January 31, 2017 (See Note 4 – Common Stock). The Company performed a revaluation of the embedded conversion liability using the Black Scholes Pricing Model on each of the ten conversion dates that resulted in a calculated embedded conversion liability value of (1) $380,511, (2) $328,745, (3) $297,684, (4) $431,000, (5) $295,424, (6) $260,433, (7) $251,876, (8) $242,909, (9) $$186,323 and (10) $497,281. The Company recorded a total expense of $139,051 for the change in the fair value of compound embedded derivative, recorded to other income (expense) in the unaudited financial statements. Additionally, the Company reclassified $112,824 of embedded conversion option liability to additional paid in capital for the change in the fair value of compound embedded derivative related to the share conversion on the respective dates. For the ten conversion dates of (1) November 2, 2016, (2) November 15, 2016, (3) December 13, 2016, (4) December 16, 2016, (5) December 23, 2016, (6) December 29, 2016, (7) January 6, 2017, (8) January 12, 2017, (9) January 23, 2017 and (10) January 24, 2017, the revaluation of the embedded conversion liability was calculated using the Black Scholes Pricing Model with the following assumptions; stock price (1) $0.21, (2) $0.17 (3) $0.14, (4) $0.17, (5) $0.13, (6) $0.12, (7) $0.10, (8) $0.10, (9) $0.08 and (10) $0.12, conversion price (1) $0.14, (2) $0.12, (3) $0.10, (4) $0.09, (5) $0.09, (6) $0.08, (7) $0.07, (8) $0.07, (9) $0.06 and (10) $0.05, expected term of (1) 0.35 years (2) 0.31 years, (3) 0.24 years, (4) 0.23 years, (5) 0.21 years, (6) 0.19 years, (7) 0.17 years, (8) 0.15 years, (9) 0.12 years and (10) 0.12 years, expected volatility of (1) 175%, (2) 177%, (3) 175%, (4) 175%, (5) 176%, (6) 176%, (7) 174%, (8) 173%, (9) 179% and (10) 179% and discount rate of (1) 0.36%, (2) 0.50%, (3) 0.54%, (4) 0.50%, (5) 0.51%, (6) 0.46%, (7) 0.52%, (8) 0.51%, (9)0.51% and (10) 0.50%. The change in the derivative liability assumed that (1) 3,500,000, (2) 3,924,206 (3) 4,655,067, (4) 4,718,254, (5) 4,924,539, (6), 4,941,867, (7) 5,551,213, (8) 5,851,953, (9) 6,553,350 and (10) 7,108,836 shares would be issued upon conversion of the promissory note. The Company performed a revaluation of the embedded conversion liability using the Black Scholes Pricing Model at January 31, 2017 that resulted in a calculated value of $596,602. The Company recorded $99,321 of expense for the change between January 24, 2017 and January 31, 2017 in the fair value of compound embedded derivative, recorded as a separate item in other income (expense) in the accompanying unaudited financial statements. The revaluation of the embedded conversion liability at January 31, 2017 was calculated using the Black Scholes option pricing model with the following assumptions; stock price $0.14, conversion price $0.05, expected term of 0.10 years, expected volatility of 181% and discount rate of 0.52%. The change in the derivative liability assumed that 6,748,354 shares would be issued upon conversion of the promissory note at January 31, 2017. For the nine months ended January 31, 2017, the Company recorded $415,890 for amortization of the four debt discounts discussed above to interest expense in the accompanying unaudited financial statements.

STOCK BASED COMPENSATION

STOCK BASED COMPENSATION	9 Months Ended
	Jan. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
STOCK BASED COMPENSATION	NOTE 3 – STOCK BASED COMPENSATION Stock Options In May 8, 2006, the Company approved the 2006 Equity Incentive Plan ("2006 Plan") for the benefit of our directors, officers, employees and consultants, and which reserved 400,000 shares of our common stock for such persons pursuant to the 2006 Plan. The 2006 Plan has a term of 10 years and no option shall be exercisable more than 10 years after the date of grant, or such lesser period of time as is set forth in the award agreement. If for any reason other than death or disability, an Optionee of the 2006 Plan who at time of the grant of an Option under the 2006 Plan was an employee ceases to be an employee (such event being called a "Termination"), options held at the date of Termination (to the extent then exercisable) may be exercised in whole or in part at any time within three months of the date of such Termination; provided, however, that if such exercise of the option would result in liability for the optionee under Section 16(b) of the Securities Exchange Act of 1934, then such three-month period automatically shall be extended until the tenth day following the last date upon which optionee has any liability under Section 16(b) (but in no event after the expiration date of such Option). There are 40,000 options outstanding under this plan at January 31, 2017. On July 14, 2014, the Company's board of directors approved the 2014 Employee Stock Plan ("2014 Plan") and authorized 10,000,000 shares of its common stock that shall be set aside and reserved for issuance pursuant to the 2014 Plan, subject to adjustments as may be required in accordance with the terms of the 2014 Plan. The 2014 Plan was subsequently approved by the Company's stockholders on November 11, 2014. The 2014 Plan has a term of 10 years and no option shall be exercisable more than 10 years after the date of grant, or such lesser period of time as is set forth in the award agreement. If for any reason other than death or disability, an optionee of the 2014 Plan who at time of the grant of an option under the 2014 Plan was an employee ceases to be an employee (such event being called a "Termination"), options held at the date of Termination (to the extent then exercisable) may be exercised in whole or in part at any time within three months of the date of such Termination; provided, however, that if such exercise of the option would result in liability for the optionee under Section 16(b) of the Securities Exchange Act of 1934, then such three-month period automatically shall be extended until the tenth day following the last date upon which optionee has any liability under Section 16(b) (but in no event after the expiration date of such option). Stock Options to Consultants Effective July 14, 2014, the Company granted 4,150,000 stock options to purchase common stock to consultants pursuant to the 2014 Plan and shall vest pursuant to the vesting provision contained in each of the stock option agreements. The exercise price of the stock options is $0.05 per share. Of the 4,150,000 stock options, 1,100,000 vested immediately on the grant date of July 14, 2014 and the remaining 3,050,000 vest over a period of three to four years based upon the specific consulting agreements. The Company valued the stock options in accordance with ASC 505, Stock Compensation – Non-Employees, by using the Black Scholes Pricing Model. The 1,100,000 stock options that vested immediately on the grant date of July 14, 2014 were valued at $55,000 and charged to consulting expense. In January 2015, 300,000 of the vested stock options were exercised leaving a balance of 800,000 unexercised vested stock options at July 31, 2015. The remaining 3,050,000 unvested stock options are being re-measured by the Company each reporting period and the resulting fair value is used to determine the new remaining consulting expense to be recorded over the vesting period of three to four years. Effective in December 2014, 1,050,000 of the unvested stock options were canceled due to the termination of the underlying consulting agreements. The consulting expense for the remaining 2,000,000 unvested stock options was reduced by $87,256 for the nine months ended January 31, 2017. The Company used the following assumptions in estimating fair value: Stock Price (re-measurement date of January 31, 2017) $ 0.14 Exercise Price $ 0.05 Expected Remaining Term 7.45 years Volatility 181 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.52 % Stock Options to Employees On February 24, 2015, pursuant to the terms of the 2014 Employee Stock Plan the Company issued to its employees, options to purchase up to 2,900,000 shares of common stock at an exercise price of $0.30 per share. The options vest over a period of 4 years, with 580,000 options vesting immediately. These options expire on February 23, 2025. In addition, on February 24, 2015, the Company granted Jerome Vainisi, the Company’s acting Chief Executive Officer, an option to purchase up to 3,000,000 shares of common stock at an exercise price of $0.30 per share. They vested over a two-year period, with 250,000 options vesting immediately and the remaining 2,750,000 options vesting in eight equal quarterly installments of 343,750 options. Effective December 11, 2015, Mr. Vainisi notified the Company that he would not finalize his employment agreement and is no longer the Company’s Chief Executive Officer and he retained all vested options and the unvested options would be forfeited. At January 31, 2016, 1,281,250 (250,000 that vested immediately and 1,031,250 that vested as per above) of the options were vested and the remaining 1,718,750 were forfeited. In accordance with the Company’s 2014 Employee Stock Plan, Mr. Vainisi has 90 days from the separation date of December 11, 2015, or March 10, 2016 to exercise the vested options or they expire. Mr. Vainisi did not exercise the 1,281,250 vested options by March 10, 2016 and they expired. The aggregate 5,900,000 stock options (2,900,000 plus 3,000,000 to Mr. Vainisi) were granted on February 24, 2015. Of the 5,900,000 stock options, 830,000 vested immediately on the grant date of February 24, 2015 and the remaining 5,070,000 would vest over a period of two to four years based upon the specific agreement. As discussed above, 1,718,750 of Mr. Vainisi’s unvested options were forfeited on December 11, 2015 and 1,281,250 of Mr. Vainisi’s vested options expired on March 10, 2016. A total of 2,070,000 unvested options are outstanding at January 31, 2017. The Company valued the 2,070,000 unvested stock options in accordance with ASC 718, Stock Compensation, using the Black Scholes Pricing Model to estimate fair value. The Company used the 'simplified method' for estimating the ‘remaining expected contractual term' because it does not have sufficient information to make more accurate estimates of the remaining expected term or employee exercise behavior (e.g., employee exercise patterns by industry and/or other categories of companies). The 830,000 stock options that vested immediately (including 250,000 for Mr. Vainisi) on the grant date were valued at $390,100 and recorded to stock based compensation expense. Effective September 30, 2015, 10,000 of the vested stock options were exercised at $0.30 per share resulting in $3,000 of proceeds to the Company. The remaining 2,070,000 unvested stock options had a fair value of $1,090,400 on the grant date and are being amortized ratably over the vesting periods. For the nine months ended January 31, 2017, the Company recorded $171,301 in stock based compensation expense. The Company used the following assumptions in estimating fair value: Stock Price (grant date) $ 0.47 Exercise Price $ 0.30 Expected Remaining Term 5 years Volatility 246 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.11 % Effective June 10, 2016, the Company granted 1,910,000 options to purchase common stock to five employees. The exercise price is $0.31 per share and on the grant date, 102,500 of the options vested immediately and the remaining 1,807,500 options vest in various stages over a three-year period. The Company valued the stock options in accordance with ASC 718, Stock Compensation, using the Black Scholes Pricing Model to estimate fair value. The Company used the 'simplified method' for estimating the ‘remaining expected contractual term' because it does not have sufficient information to make more accurate estimates of the remaining expected term or employee exercise behavior (e.g., employee exercise patterns by industry and/or other categories of companies). The 102,500 stock options that vested immediately on the grant date were valued at $32,717 and were recorded to stock based compensation expense. The remaining 1,807,500 unvested stock options had a fair value of $576,944 on the grant date and will be amortized ratably over the vesting periods. For the nine months ended January 31, 2017, the Company recorded $499,946 of stock based compensation expense related to the 1,807,500 unvested stock options. The Company used the following assumptions in estimating fair value: Stock Price (grant date) $ 0.32 Exercise Price $ 0.31 Expected Remaining Term 10 years Volatility 191 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.27 % On August 4, 2016, pursuant to the terms of the 2014 Employee Stock Plan the Company issued to an employee, an option to purchase 50,000 shares of common stock at an exercise price of $0.30 per share. The options vest over a period of 3 years, with 20,000 vesting immediately. This option expires on August 3, 2026. The Company valued the options in accordance with ASC 718, Stock Compensation, using the Black Scholes Pricing Model to estimate fair value. The Company used the 'simplified method' for estimating the ‘remaining expected contractual term' because it does not have sufficient information to make more accurate estimates of the remaining expected term or employee exercise behavior (e.g., employee exercise patterns by industry and/or other categories of companies). The 20,000 stock options that vested immediately on the grant date were valued at $3,418 and were recorded to stock based compensation expense. The remaining 30,000 unvested stock options had a fair value of $5,233 on the grant date and are being amortized ratably over the vesting periods. During the nine months ended January 31, 2017, the Company recorded $1,738 of stock based compensation expense. The Company used the following assumptions in estimating fair value: Stock Price (grant date) $ 0.18 Exercise Price $ 0.30 Expected Remaining Term 5 years Volatility 184 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.26 % The following table summarizes employee and consultant stock option activity of the Company for the nine months ended January 31, 2017: Employee and Consultant Stock Options Outstanding Weighted Weighted Average Average Remaining Aggregate Number of Exercise Contractual Intrinsic Options Price Life (Years) Value Outstanding, April 30, 2016 5,730,000 $ 0.18 7.73 $ 252,280 Issued June 10, 2016 1,910,000 $ 0.31 9.36 — Issued August 4, 2016 50,000 $ 0.30 9.51 — Outstanding, January 31, 2017 7,690,000 $ 0.22 8.14 $ 252,280 Exercisable, January 31, 2017 2,547,500 $ 0.22 7.74 $ 110.373 Stock Warrants Effective August 28, 2015, the Company granted 1,400,000 warrants to purchase common stock, exercisable at $0.35 per share, to a consultant for services to be provided over a one-year period. Additionally, the Company issued 400,000 shares of stock to the Consultant as compensation for the services. Of the 1,400,000 stock warrants, 700,000 vested immediately on the grant date of August 28, 2015 and the remaining 700,000 vest six (6) months from the grant date on February 28, 2016. The warrant has an exercise period of thirty (30) months through August 28, 2018. The Company valued the stock warrant in accordance with ASC 505-50, Equity Based Payments to Non-Employees, using the Black Scholes Pricing Model to determine the fair value. According to ASC 505-50, a measurement date was reached at the date of grant, or August 28, 2015 for the 700,000 warrants which vested on the grant date. For the 700,000 warrants that vest in six (6) months, the fair value was re-valued at each reporting date until the vesting date of February 28, 2016. The 700,000 stock warrants that vested immediately on the grant date were valued at $289,867, recorded to prepaid expense and will be amortized ratably to consulting expense over the twelve (12) month service period. The Company recorded $94,505 of consulting expense for the 700,000 vested stock warrants for the nine months ended January 31, 2017. The prepaid balance is zero at January 31, 2017. The Company used the following assumptions in estimating fair value: Stock Price (grant date) $ 0.42 Exercise Price $ 0.35 Expected Remaining Term 2.33 years Volatility 317 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.30 % The remaining 700,000 unvested stock warrants had a fair value of $289,867 on the grant date and will also be amortized ratably to consulting expense over the twelve (12) month service period, however these warrants were re-valued through the vesting date of February 28, 2016, and the adjusted valuation, less the amounts amortized through the vesting date, have been amortized over the remaining service period of six (6) months. For the final re-measurement at February 28, 2016, the valuation was adjusted to $680,821 and the unamortized prepaid expense balance was $221,966 at April 30, 2016. For the nine months ended January 31, 2017, the Company recorded $221,966 of consulting expense. The prepaid balance is zero at July 31, 2017. The Company used the following assumptions in estimating fair value: Stock Price (re-measurement date of February 28, 2016) $ 1.00 Exercise Price $ 0.35 Expected Remaining Term 1.83 years Volatility 293 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.32 % In relation to the 400,000 shares issued on the grant date, the Company valued the stock based upon the quoted market price of $0.42 on the date of grant, or $168,000. The $168,000 was amortized to consulting expense over the one-month term of the consulting agreement and the unamortized prepaid consulting balance was $54,773 at April 30, 2016. During the nine months ended January 31, 2017, the Company recorded $54,773 of consulting expense. The prepaid balance is zero at October 31, 2016. As discussed above in Note 2 – Debt, in relation to a convertible secured promissory note, the Company issued the lender two warrants, a Series A warrant with a three (3) year term to acquire 250,000 shares of common stock of the Company at an exercise price of $1.02 per share and a Series B warrant with a three (3) year term to acquire 250,000 shares of common stock of the Company at an exercise price of $1.19 per share. Effective June 10, 2016, the Company granted 2,400,000 warrants to purchase common stock, exercisable at $0.01 per share, to six (6) consultants for prior services provided. The warrants vested immediately and have an exercise period of three years. The Company valued the stock warrants in accordance with ASC 505-50, Equity Based Payments to Non-Employees, using the Black Scholes Pricing Model to determine the fair value. The fair value for these stock warrants was $758,808, which was recorded to consulting expense immediately. The Company used the following assumptions in estimating fair value: Stock Price (grant date) $ 32 Exercise Price $ 0.01 Expected Remaining Term 3 years Volatility 191 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.27 % Effective August 4, 2016, the Company granted 400,000 warrants to purchase common stock, exercisable at $0.01 per share, to a consultant for corporate strategy services. The warrants vested immediately and have an exercise period of two years. The Company valued the stock warrants in accordance with ASC 505-50, Equity Based Payments to Non-Employees, using the Black Scholes Pricing Model to determine the fair value. The fair value for these stock warrants was $69,741, which was recorded to consulting expense immediately. The Company used the following assumptions in estimating fair value: Stock Price (grant date) $ 0.18 Exercise Price $ 0.01 Expected Remaining Term 2 years Volatility 184 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.26 % In January 2017, the Company commenced a $400,000 private placement offering eight (8) units at $50,000 per unit. Each unit represents 500,000 shares of common stock at $0.10 per share and a warrant to purchase 250,000 shares of common stock for one year at an exercise price of $1.00 per share. From January 12, 2017 through January 26, 2017, the Company received $61,000 of proceeds from the offering representing 610,000 shares of stock and 305,000 warrants. See Note 4 – Common Stock. The $61,000 of proceeds from the issuance of the units was allocated between the shares of common stock and the warrants based on their relative fair values on the date of issuance. The fair value for the warrants was determined utilizing the Black Scholes Pricing Model based upon the various issuance dates of the warrants during the period. The Company allocated $55,806 to the shares of stock and $5,194 to the warrants. The value allocated to the warrants was classified as additional paid in capital in the accompanying financial statements. The following table summarizes stock warrant activity of the Company for the nine months ended January 31, 2017: Consultant Stock Warrants Outstanding Weighted Weighted Average Average Remaining Aggregate Number of Exercise Contractual Intrinsic Warrants Price Life (Years) Value Outstanding, April 30, 2016 7,193,746 $ 0.24 0.98 $ 310,255 Issued June 10, 2016 2,400,000 $ 0.01 2.35 312,240 Issued August 4, 2016 400,000 $ 0.01 1.50 $ 52,040 Issued January 12, 2017 through January 26, 2017 305,000 $ 1.00 0.95 — Outstanding, January 31, 2017 10,298,746 $ 0.20 1.32 $ 674,535 Exercisable, January 31, 2017 10,298,746 $ 0.20 1.32 $ 674,535

COMMON STOCK

COMMON STOCK	9 Months Ended
	Jan. 31, 2017
Stockholders' Equity Note [Abstract]
COMMON STOCK	NOTE 4 – COMMON STOCK Capital Structure The Company is authorized to issue up to 150,000,000 shares of common stock at $0.001 par value per share. At January 31, 2017, 48,967,203 shares were issued and outstanding. Additionally, there are 1,500,000 shares of unvested common stock to be issued to employees over the vesting period of four years through July 14, 2018. The 1,500,000 unvested shares of common stock are not included in the 48,967,203 shares reported but are considered legally issued and outstanding as they have all rights of ownership, other than the right to receive dividends, and in the case of 1,500,000 of the shares, the right to vote. Common Stock Issued On July 14, 2014, the Company granted 19,000,000 shares of its common stock to the new MLFB management team. Of the 19,000,000 shares, 12,000,000 vested immediately and the remaining 7,000,000 vested in equal annual installments over a 4-year employment period commencing July 2015. During the three months ended July 31, 2015 and July 31, 2016, 3,500,000 of the 7,000,000 shares vested leaving a balance of 3,500,000 unvested shares at July 31, 2016. Effective August 31, 2016, 2,000,000 of the unvested shares were vested leaving a balance of 1,500,000 unvested shares at October 31, 2016. The Company recorded the issuance of the 5,500,000 vested shares at its par value of $5,500 with an offset to additional paid in capital. The original 7,000,000 unvested shares were valued at $0.05 per share or $350,000 and are being amortized to compensation expense over the vesting period. During the nine months ended January 31, 2017, the Company recorded $138,494 of compensation expense related to vesting of the shares. Effective March 23, 2015, the Company engaged a consultant to provide services primarily related to strategic planning, business development and strategic advisory services. The term of the agreement is two (2) years and as compensation for the agreement, the Company issued the consultant 500,000 shares of common stock. The Company valued the stock based upon the quoted market price of $0.30 on the date of grant, or $150,000. The $150,000 is being amortized to consulting expense over the two-year term of the consulting agreement. During the nine months ended January 31, 2017, the Company recorded $56,250 of consulting expense and the remaining unamortized amount of $10,736 is recorded as prepaid consulting at January 31, 2017. Effective October 15, 2015, the Company engaged a consultant to provide services primarily related to media services. The term of the agreement is one (1) year and as compensation for the agreement, the Company issued the consultant 112,500 shares of common stock. The Company valued the stock based upon the quoted market price of $1.00 on the date of grant, or $112,500. The $112,500 is being amortized to consulting expense over the one-year term of the consulting agreement. During the nine months ended January 31, 2017, the Company recorded $51,111 of consulting expense and the prepaid consulting amount has been fully amortized at January 31, 2017. Effective December 8, 2015, the Company engaged a consultant to provide services primarily related to public relations services. The term of the agreement is six (6) months and as compensation for the agreement, the Company issued the consultant 500,000 shares of common stock. The Company valued the stock based upon the quoted market price of $0.72 on the date of grant, or $275,000. The $275,000 is being amortized to consulting expense over the six-month term of the consulting agreement. During the nine months ended January 31, 2017, the Company recorded $55,907 of consulting expense and the prepaid consulting amount has been fully amortized at January 31, 2017. Effective January 1, 2016, the Company engaged three consultants to provide services primarily related to corporate strategies. The term for each of the three agreements is six (6) months and as compensation for the agreement, the Company issued the three consultants an aggregate 150,000 shares of common stock. The Company valued the stock based upon the quoted market price of $0.72 on the date of grant, or $108,000. The $108,000 is being amortized to consulting expense over the six-month term of the consulting agreement. During the nine months ended January 31, 2017, the Company recorded $72,000 of consulting expense and the prepaid consulting amount has been fully amortized at January 31, 2017. Effective January 14, 2016, the Company engaged a consultant to provide services primarily related to corporate strategies. The term of the agreement is six (6) months and as compensation for the agreement, the Company issued the consultant 100,000 shares of common stock. The Company valued the stock based upon the quoted market price of $0.80 on the date of grant, or $80,000. The $80,000 is being amortized to consulting expense over the six-month term of the consulting agreement. During the nine months ended January 31, 2017, the Company recorded $32,527 of consulting expense and the prepaid consulting amount has been fully amortized at January 31, 2017. From May 3, 2016 to June 10, 2016, the Company issued 160,132 shares of common stock to employees as a component of a Registration Statement on Form S-8 for an aggregate of 8,690,000 shares of the Company’s common stock. The shares were issued per the Company’s 2014 Employee Stock Plan. The Company valued the stock based upon the quoted market price at prices ranging from of $0.32 to $0.51 on the date of grant, or $66,062 and was classified as stock compensation expense for the nine months ended January 31, 2017 in the accompanying unaudited financial statements Effective May 4, 2016, the Company issued 91,860 shares of common stock to a former consultant to settle a dispute related to the exercise price of a warrant previously provided with a cashless option. The Company valued to issuance of stock based upon the quoted market price of $0.45 on the date of issuance. During the six months ended October 31, 2016, the Company recorded $41,337 of consulting expense related to the issuance of common stock. On (1) September 13, 2016, (2) September 30, 2016 (3) October 26, 2016, (4) November 2, 2016, (5) November 15, 2016, (6) December 13, 2016, (7) December 16, 2016, (8) December 23, 2016, (9) December 29, 2016, (10) January 6, 2017, (11) January 12, 2017, (12) January 23, 2017 and (13) January 24, 2017, the lender of a convertible secured promissory, elected to exercise their right to convert on each of the above dates an aggregate amount of $150,000 of the October 31, 2016 $505,000 principal balance and the note payable balance is $355,000 at January 31, 2017 (See Note 2 – Debt). The lender has the right at any time after the effective date, at its election, to convert all or part of the outstanding and unpaid principal sum and accrued interest into shares of common stock of the Company, subject to certain conversion limitations set forth in the promissory note and certain price protection described below, as per the conversion formula: Number of shares receivable upon conversion equals the dollar conversion amount divided by the Conversion Price. The Conversion Price is equal to seventy percent (70%) of the average of the lowest three VWAPs of the Common Stock during the twenty (20) Trading Days immediately preceding a Conversion Date. Based upon the calculated Conversion Prices of (1) $0.18, (2) $0.17, (3) $0.15 (4) $0.21, (5) 0.17, (6) $0.14, (7) 0.17, (8) $0.13, (9) $0.12, (10) $0.10, (11) $0.10, (12) $0.08 and (13) $0.12 on the respective conversion dates, the Company issued 2,015,134 shares of common stock to the lender. Effective August 4, 2016, two of the Company’s consultants exercised a total of 1,300,000 warrants at an exercise price of $0.01 or $13,000 of consideration. The two consultants paid for the exercise price of $13,000 by electing the cashless exchange option included in the warrant to decrease the balance due under their respecting consulting invoices. On October 26, 2016, the Company issued 27,000 shares of common stock to employees as a component of a Registration Statement on Form S-8 for an aggregate of 8,690,000 shares of the Company’s common stock. The shares were issued per the Company’s 2014 Employee Stock Plan. The Company valued the stock based upon the quoted market price of $0.22 per share on the date of grant, or $5,940 and was classified as stock compensation expense for the nine months ended January 31, 2017 in the accompanying unaudited financial statements. From January 12, 2017 through January 26, 2017, the Company received $61,000 of proceeds from a private placement offering representing 610,000 shares of stock and 305,000 warrants. See Note 3 – Stock Based Compensation, Note 6 – Commitments and Contingencies and Note 7 – Subsequent Events. The $61,000 of proceeds from the issuance of the units was allocated between the shares of common stock and the warrants based on their relative fair values on the date of issuance. The fair value for the warrants was determined utilizing the Black Scholes Pricing Model based upon the various issuance dates of the warrants during the period. The Company allocated $55,806 to the shares of stock and $5,194 to the warrants. The value allocated to the warrants was classified as additional paid in capital in the accompanying financial statements.

RELATED PARTY TRANSACTIONS

RELATED PARTY TRANSACTIONS	9 Months Ended
	Jan. 31, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 – RELATED PARTY TRANSACTIONS During the nine months ended January 31, 2017, the Company recorded $675,000 of accrued and unpaid compensation for its management in accordance with executed management service agreements. At January 31, 2017, a total of $1,635,000 was unpaid and is recorded as accrued officer compensation in the accompanying unaudited financial statements. Additionally, during the nine months ended January 31, 2017, the Company recorded $40,198 of employers share of payroll taxes related to the unpaid officer compensation resulting in accrued officer payroll taxes of $91,039 at January 31, 2017. From February to July 2015, an officer of the Company provided $15,300 of funds for working capital requirements. There is no formal agreement and no interest is being accrued by the Company with the principal due on demand. During the three months ending October 31, 2015, the Company repaid $15,000 of these funds leaving a balance outstanding of $300. Effective August 28, 2015, the officer personally repaid $20,000 of notes payable for the Company resulting in a balance outstanding of $20,300. During the three months ending January 31, 2017, the Company repaid $5,000 of these funds and the outstanding balance owed to the officer was $15,300 at January 31, 2017, recorded as Notes Payable – Related Parties in the accompanying unaudited financial statements. See Note 2 – Debt and Note 7 – Subsequent Events. During the nine months ended January 31, 2017, an officer of the Company and another individual closely affiliated with the Company, advanced $6,646 of funds to the Company for working capital purposes. The Company has recorded these advances as accounts payable – related parties in the accompanying unaudited financial statements at January 31, 2017.

COMMITMENTS AND CONTINGENCIES

COMMITMENTS AND CONTINGENCIES	9 Months Ended
	Jan. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 6 – COMMITMENTS AND CONTINGENCIES On July 31, 2015, the Company executed a lease agreement for its new corporate headquarters and training facility in Lakewood Ranch, Manatee County, Florida. The term of the lease is two (2) years at a monthly rental rate of $11,918. At closing, the Company paid an $11,918 security deposit, which is recorded in other assets in the accompanying financial statements at April 30, 2016. The Company has an option to extend the terms and conditions of the lease for an additional three (3) years by giving notice at least six (6) months before the expiration of the term. On June 2, 2016, the Company received a notice of default letter related to the corporate office lease in Florida. The letter demanded payment for the full amount outstanding within seven days or the Landlord may pursue all legal remedies including termination of the lease. On June 22, 2016, the Company received a complaint notice as the defendant in a lawsuit filed related to the corporate office lease in Florida. The lawsuit claimed that the Company is indebted to the landlord in an amount more than $57,857 for unpaid rent plus an additional $224,596 for accelerated rent for a total of $282,453, but the landlord does not specifically seek the additional $224,596 for accelerated rent in its complaint, although the court may later determine that the landlord is entitled to the accelerated rent amount. At October 31, 2016, the Company had not paid the landlord for the Florida corporate offices approximately $58,000 of lease payments and was in default of the lease agreement and subject to eviction, acceleration of the entire lease amount and other legal remedies that the landlord may pursue. On August 5, 2016, the Company paid $100,000 for the settlement of the lawsuit filed by the landlord and discussed above. The $100,000 payment was for an outstanding of $98.173, which included $3,699 in attorney's fees and the August 1, 2016 rent. During the three months ended January 31, 2017, the Company has made all required payments under the rental agreement and considers the default has been cured. At January 31, 2017, the total future minimum lease payments under operating leases in respect of leased premises are payable as follows: 2017 $ 71,508 2018 35,754 Total $ 107,262 On May 9, 2009, Stradley Ronon Stevens & Young, LLP, filed a lawsuit against the Company in the U.S. District Court for the District of Delaware for failure of the Company to pay legal fees owed in the amount of $166,129. On April 2, 2009, in order to avoid the cost of litigation, the Company agreed to a Consent of Judgment against it in the amount of $166,129 and the Company continues to carry this amount as accounts payable at April 30, 2016. The Company negotiated with Stradley and in July 2014, agreed to issue Stradley 100,000 shares of common stock valued at $0.05 per share, the quoted market price on the date of grant, as a sign of good faith in regards to a resolution. The Company is still in discussions with the law firm in regard to this Judgment and anticipates a resolution in the near future. On February 5, 2016, the Company disclosed that the previously executed $20,000,000 sale and purchase of common stock with Clairemont Private Investment Group, LLC (“Clairemont”), scheduled to close on February 1, 2016 was in default. The Company disclosed that Clairemont breached the Amended Purchase Agreement by not providing to the Company the $20,000,000 purchase price for the common stock as required by the terms of the Amended Purchase Agreement. The Company intends to pursue legal remedies against Clairemont. H&J Ventures, LLC (“H&J”) is a debtor in a chapter 7 bankruptcy proceeding. On October 4, 2016, the chapter 7 trustee (the “Trustee”) of the bankruptcy estate of H&J sent a letter to the Company claiming that the Company owed $7,800,000 to H&J in connection with an October 1, 2014 agreement between the Company and H&J, and that the Trustee would accept a settlement payment of $6,630,000 to resolve the matter. The Company disputes this claim in its entirety. On December 9, 2016, the Trustee served the Company with a subpoena relating to this matter. The Company has retained counsel with respect to this matter and will respond to the subpoena as it is lawfully required to do; however, the Company considers this claim to be without merit. The Company engaged a law firm to assist in the matter and on January 23, 2017, paid a $7,500 retainer, classified as prepaid legal in the accompanying unaudited financial statements at January 31, 2017. From January 13, 2017 through January 26, 2017, the Company received an aggregate $61,000 of cash proceeds from four individuals related to the $400,000 Private Placement Offering discussed earlier – See Note 3 – Stock Compensation and Note 4 – Common Stock. At January 31, 2017, the four individuals had not complete and signed their respective stock subscription agreements. Accordingly, the Company classified the $61,000 as advances, a current liability in the accompanying unaudited financial statements at January 31, 2017. See Note 7 – Subsequent Events. Unpaid Taxes and Penalties At January 31, 2017, the Company owed the State of Delaware $110,154 for unpaid state income taxes from the tax year ended April 30, 2007. The unpaid state income taxes are included as state income taxes payable in accompanying unaudited financial statements at January 31, 2017. Additionally, the Company owes the State of Delaware for penalties and interest from the tax year ending April 30, 2007 of $177,717, which is included as accrued expenses in the accompanying unaudited financial statements at January 31, 2017. The Company has an agreement with the State of Delaware to pay a minimum per month. However, due to cash flow constraints, the Company has been unable to pay the minimum monthly amounts and is in default of the agreement that may cause additional interest and penalties and lead to other collection efforts by the State of Delaware. In September 2015, the Company reached an offer in compromise (“OIC”) settlement with the IRS for unpaid penalties and interest from the tax year ended April 30, 2007. The settlement was in the amount of $13,785 and was to be paid by the Company with a $1,000 payment upon the execution of settlement, then the balance of $1,757 paid in November 2015 and making up the 20% down payment of $2,757, a second installment payment of $2,208, and then four monthly payments of $2,205. Through July 31, 2016, the Company had made all required payments in accordance with the settlement except for the final payment of $2,205. The Company received correspondence from the IRS that because of an application fee note being paid with the original OIC, the Company was required to submit a new OIC and the required application fee. In October 2016, the Company had a telephone call with an IRS representative and were informed to offer the last payment that was due on the original OIC of $2,205 as discussed above and pay 20% of that balance. On October 5, 2016, the Company sent to the IRS by certified mail two checks in the amount of $186 (application fee for the new OIC) and $449 (20% or $441 of the $2,205 remaining original OIC payment and an $8 processing fee). The Company applied $441 against the remaining payment owed and the balance of $1,764 is included in accrued expenses in the accompanying unaudited financial statements at January 31, 2017. As of the date of these unaudited financial statements, the Company has not received any further correspondence form the IRS and the Company is considered in default of the settlement agreement and the IRS could void or restructure the agreement.

SUBSEQUENT EVENTS

SUBSEQUENT EVENTS	9 Months Ended
	Jan. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 7 – SUBSEQUENT EVENTS On (1) February 1, 2017, (2) February 6, 2017, (3) February 8, 2017, (4) February 14, 2017, (5) February 17, 2017, (6) March 2, 2017, (7) March 3, 2017, (8) March 8, 2017 and (9) March 14, 2017, the lender of a convertible secured promissory, elected to exercise their right to convert (1) $15,000, (2) $15,000, (3) $15,000, (4) $30,000, (5) $20,000, (6) $15,000, (7) $15,000, (8) $15,000 and (9) $15,000 on each of the above dates of the remaining $355,000 principal balance and the note payable balance is $200,000 after the conversions (See Note 2 – Debt). The lender has the right at any time after the effective date, at its election, to convert all or part of the outstanding and unpaid principal sum and accrued interest into shares of common stock of the Company, subject to certain conversion limitations set forth in the promissory note and certain price protection described below, as per the conversion formula: Number of shares receivable upon conversion equals the dollar conversion amount divided by the Conversion Price. The Conversion Price is equal to seventy percent (70%) of the average of the lowest three VWAPs of the Common Stock during the twenty (20) Trading Days immediately preceding a Conversion Date. Based upon the calculated Conversion Prices of (1) $0.05, (2) $0.05, (3) $0.05, (4) $0.05, (5) $0.05, (6) $0.06, (7) $0.06(8) $0.06 and (9) $0.05 on the respective conversion dates, the Company issued an aggregate 2,722,098 shares of common stock to the lender. On March 9, 2017, the Company and the Lender of the above convertible secured promissory note with a remaining principal balance of $215,000 on that date, executed a forbearance agreement extending the note expiration date from March 9, 2017 to June 9, 2017 (See Note 2 – Debt). The terms of the forbearance agreement included that the Company (1) will have paid all remaining principal and accrued interest by June 9, 2017, (2) will issue 500,000 shares of common stock to the lender, (3) will pay the lender’s legal fees estimated to be approximately $2,000 before April 30, 2017, (4) will issue the lender 500,000 warrants to purchase common stock at $0.10 per share with a three-year term and (5) the outstanding principal balance of the note will bear interest at the “Default Interest” rate of twenty-two percent (22%), as defined in the note agreement. The Company evaluated the forbearance agreement as to whether it was an extinguishment or modification of debt. In concluding on the accounting, the Company evaluated ASC 470-50, Debtor’s Accounting for a Modification or Exchange of Debt Instruments. The Company determined that the forbearance agreement was not an extinguishment of debt or a material modification. The Company will adjust the carrying amount of the debt for any premium or discount, including stock and warrant issuances, and will amortized over the modification period of three months through June 9, 2017. The Company evaluated the warrant and determined that there was no derivative treatment required as the warrant contained a fixed exercise price with an adjustment only based upon customary items including stock dividends and splits, subsequent rights offerings and pro rate distributions. The Company calculated the relative fair value between the outstanding principal of the note ($215,000) and the warrant on March 9, 2017 utilizing the Black Scholes Pricing Model for the warrant. The Company allocated $28,015 to the warrant which will be recorded as a debt discount with an offset to additional paid in capital in the unaudited financial statements. The warrant calculation used the following assumptions; stock price $0.08, warrant exercise price $0.10, expected term of 3 years, expected volatility of 173% and discount rate of 0.75%. The Company valued the 500,000 shares of common stock issued to the lender based upon the quoted market price of $0.08 on March 9, 2017, the date of grant, or $40,000, recorded as a debt discount with an offset to additional paid in capital. In total on the forbearance date of March 9, 2017, the Company will record the following debt discounts as offsets to the $215,000 note payable which will be amortized over the 90- day term of the forbearance agreement through June 9, 2017: (1) (1) warrant relative fair value of $28,015 and (2) common stock relative fair value of $29,331. On February 2, 2017, the Company repaid $11,000 of principal related to an outstanding balance owed to an officer that was $15,300 at January 31, 2017, recorded as Notes Payable – Related Parties in the accompanying unaudited financial statements. See Note 2 – Debt and Note 5 – Related Party Transactions. The outstanding balance of the promissory note is $4,300 as of the date of these unaudited financial statements. On (1) February 16, 2017, (2) March 2, 2017 and (3) March 6, 2017, the Company repaid (1) $25,000, (2) $20,000 and (3) $25,000 of principal related to an original $130,000 promissory note dated August 4, 2016. See Note 2 – Debt. The outstanding balance of the promissory note is $35,000 as of the date of these unaudited financial statements. Effective February 23, 2017, the four individuals representing $61,000 of advances at January 31, 2017, submitted their signed subscription agreements and the Company issued a total of 610,000 shares of Common Stock and 305,000 Warrants. See Note 6 – Commitments and Contingencies. The $61,000 of proceeds from the issuance of the units will be allocated between the shares of common stock and the warrants based on their relative fair values on the date of issuance. The fair value for the warrants was determined utilizing the Black Scholes Pricing Model based upon the various issuance dates of the warrants during the period. The Company allocated $55,996 to the shares of stock and $5,034 to the warrants. The value allocated to the warrants will be classified as additional paid in capital. From February 1, 2017 through March 3, 2017, the Company received $93,500 of proceeds representing 935,000 shares of stock and 467,500 warrants from a private placement offering discussed earlier – see Note 4 – Common Stock. The $93,500 of proceeds from the issuance of the units will be allocated between the shares of common stock and the warrants based on their relative fair values on the date of issuance. The fair value for the warrants was determined utilizing the Black Scholes Pricing Model based upon the various issuance dates of the warrants during the period. The Company allocated $84,460 to the shares of stock and $9,040 to the warrants. The value allocated to the warrants will be classified as additional paid in capital.

NATURE OF OPERATIONS, BASIS O13

NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)	9 Months Ended
	Jan. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Going Concern	Going Concern The accompanying unaudited financial statements have been prepared assuming the Company will continue as a going concern. As reflected in the accompanying unaudited financial statements, the Company had no revenues, and a net loss and negative cash from operating activities of $4,386,576 and $235,861 respectively, for the nine months ended January 31, 2017. Additionally, at January 31, 2017, the Company has a working capital deficit of $4,106,505, an accumulated deficiency of $25,508,408 and a stockholders' deficiency of $4,091,977, which could have a material impact on the Company's financial condition and operations. In view of these matters, recoverability of any asset amounts shown in the accompanying unaudited financial statements is dependent upon the Company’s ability to achieve a level of profitability. These matters raise substantial doubt about the Company’s ability to continue as a going concern. Since inception, the Company has financed its activities from the sale of equity securities and from loans. The Company intends on financing its future development activities and its working capital needs largely from the sale of public equity securities and convertible debt securities, until such time that funds provided by operations, if ever, are sufficient to fund working capital requirements. The financial statements do not include any adjustments relating to the recoverability or classification of recorded assets and liabilities that might result should the Company be unable to continue as a going concern.
Basis of Presentation	Basis of Presentation The accompanying unaudited interim period financial statements of the Company are unaudited pursuant to certain rules and regulations of the Securities and Exchange Commission and include, in the opinion of management, all adjustments (consisting of only normal recurring accruals) necessary for a fair statement of the results of the periods indicated. Such results, however, are not necessarily indicative of results that may be expected for the full year. Certain information and footnote disclosures normally included in the financial statements prepared in accordance with accounting principles generally accepted in the United States have been condensed or omitted pursuant to such rules and regulations. The accompanying unaudited financial statements should be read in conjunction with the financial statements and notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended April 30, 2016, as filed with the Securities and Exchange Commission on July 29, 2016. The interim operating results for the nine months ending January 31, 2017 are not necessarily indicative of operating results expected for the full year.
Estimates	Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying disclosures. Although these estimates are based on management’s best knowledge of current events and actions the Company may undertake in the future, actual results could differ from the estimates. Significant estimates in the accompanying financial statements include the allowance for doubtful receivables, valuation of collateral on certain receivables, valuation of derivative liabilities, valuation of beneficial conversion features in convertible debt, valuation of equity based instruments issued for other than cash, valuation allowance on deferred tax assets, depreciable lives and estimated residual value of furniture, fixtures and equipment.
Cash and Cash Equivalents	Cash and Cash Equivalents For the statements of cash flows, the Company considers all highly liquid investments with an original maturity of three months or less when purchased to be cash equivalents. There were no cash equivalents at January 31, 2017 and 2016.
Concentration of Credit Risk	Concentration of Credit Risk Certain financial instruments potentially subject the Company to concentrations of credit risk. These financial instruments consist primarily of cash. At January 31, 2017 and 2016 the Company did not have deposits with a financial institution that exceeded the FDIC deposit insurance coverage and determined that it had no cash equivalents.
Furniture, Fixtures and Equipment	Furniture, Fixtures and Equipment Furniture, fixtures and equipment are stated at cost, net of accumulated depreciation. For financial accounting purposes, depreciation is generally computed by the straight-line method over the following useful lives: Furniture and fixtures 5 to 7 years Computer and office equipment 3 to 7 years For the nine months ended January 31, 2017 and 2016, the Company recorded $348 and $181 of depreciation expense, respectively and at January 31, 2017, the accumulated depreciation balance was $13,940.
Provision for Loan Receivable and Collateral Deposit	Provision for Loan Receivable and Collateral Deposit In March 2016, the Company loaned $125,000 to a third party so that the third party could make an investment that was expected to provide an additional return to the Company. Due to significant uncertainties regarding the collectability of the original principal amount and/or any additional return, the Company recorded an allowance for the full amount of the Loan Receivable and classified as Provision for Loan Receivable in the accompanying unaudited financial statements. In April 2016, the Company disbursed $50,000 of cash related to a collateral deposit with a third party that required additional deposits before a proposed transaction could be consummated. At April 30, 2016, no further deposits had been made and the Company recorded an allowance for the full amount of the Collateral Deposit and classified as Provision for Collateral Deposit in the accompanying unaudited financial statements.
Convertible Promissory Notes Containing Embedded Derivatives	Convertible Promissory Notes Containing Embedded Derivatives We account for the embedded conversion option contained in convertible instruments under the provisions of FASB ASC Topic No. 815-40, “Derivatives and Hedging – Contracts in an Entity’s Own Stock”. The embedded conversion option contained in certain convertible instruments are bifurcated and accounted for as derivative liabilities at the date of issuance and are adjusted to fair value through earnings at each reporting date. The fair value of the embedded conversion option liabilities was determined using the Black Scholes Pricing model. On the initial measurement date, the fair value of the embedded conversion option liability was recorded as a derivative liability and was allocated as debt discount up to the proceeds of the notes with the remainder charged to current period operations as initial derivative expense. Gains and losses derived from changes in the fair value of the derivative liability were recorded as a component of other income (expense) in the accompanying statements of operations. Upon conversion of debt, the fair value of the derivative is reclassified into equity and the common stock is recorded at book value of the debt.
Fair Value of Financial Instruments	Fair Value of Financial Instruments ASC 820, Fair Value Measurements and Disclosures, requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 establishes a fair value hierarchy based on the level of independent, objective evidence surrounding the inputs used to measure fair value. A financial instrument’s categorization within the fair value hierarchy is based upon the lowest level of input that is significant to the fair value measurement. ASC 820 prioritizes the inputs into three levels that may be used to measure fair value: Level 1 Level 1 applies to assets or liabilities for which there are quoted prices in active markets for identical assets or liabilities. Level 2 Level 2 applies to assets or liabilities for which there are inputs other than quoted prices that are observable for the asset or liability such as quoted prices for similar assets or liabilities in active markets; quoted prices for identical assets or liabilities in markets with insufficient volume or infrequent transactions (less active markets); or model-derived valuations in which significant inputs are observable or can be derived principally from, or corroborated by, observable market data. If the asset or liability has a specified (contractual) term, the Level 2 input must be observable for substantially the full term of the asset or liability. Level 3 Level 3 applies to assets or liabilities for which there are unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company’s financial instruments consist principally of cash, amounts receivable, accounts payable, unsecured convertible notes payable, secured convertible notes payable, notes payable, notes payable – related party and an embedded conversion option liability. Pursuant to ASC 820, Fair Value Measurements and Disclosures and ASC 825, Financial Instruments, the Company believes that the recorded values of the other financial instruments approximate their current fair values because of their nature and respective maturity dates or durations. Assets and liabilities measured at fair value on a recurring/non-recurring basis consist of the following at January 31, 2017: Carrying Value Fair Value Measurements at At January 31, 2017 January 31, 2017 Level 1 Level 2 Level 3 Embedded conversion option liability $ 596,602 $ — $ — $ 596,602 The following is a summary of activity of Level 3 assets and liabilities for the nine months ended January 31, 2017: Embedded Conversion Option Liability Balance – April 30, 2016 $ 462,531 Loss from change in the fair value of derivative liabilities 285,435 Change in embedded derivative liability for partial conversions of a convertible secured promissory note (151,364 ) Balance – January 31, 2017 $ 596,602 Changes in fair value of the embedded conversion option liability are included in other income (expense) in the accompanying unaudited financial statements.
Revenue Recognition	Revenue Recognition League Tryout Camps The Company recognizes league tryout camp revenue on the dates that the tryout camps were held. There were no tryout camps held by the Company during the nine months ended January 31, 2017. Football League Operations The Company will recognize revenue from future football league operations including gate, parking and concessions, stadium advertising and merchandising, licensing fees, sponsorships, naming rights, broadcast and cable, franchise fees, social media and on-line digital media including merchandising, advertising and subscriptions. Since the football operations have not commenced and will not until March 2017, there was no revenue from football league operations during the nine months ended January 31, 2017.
Stock Based Compensation	Stock Based Compensation Stock-based compensation is accounted for based on the requirements of the Share-Based Payment Topic of ASC 718 which requires recognition in the financial statements of the cost of employee and director services received in exchange for an award of equity instruments over the period the employee or director is required to perform the services in exchange for the award (presumptively, the vesting period). The ASC also requires measurement of the cost of employee and director services received in exchange for an award based on the grant-date fair value of the award. Pursuant to ASC 505-50, for share-based payments to consultants and other third-parties, compensation expense is determined at the “measurement date.” The expense is recognized over the service period of the award. Until the measurement date is reached, the total amount of compensation expense remains uncertain. The Company initially records compensation expense based on the fair value of the award at the reporting date.
Income Taxes	Income Taxes Deferred income tax assets and liabilities arise from temporary differences associated with differences between the financial statements and tax basis of assets and liabilities, as measured by the enacted tax rates, which are expected to be in effect when these differences reverse. Deferred tax assets and liabilities are classified as current or non-current, depending upon the classification of the asset or liabilities to which they relate. Deferred tax assets and liabilities not related to an asset or liability are classified as current or noncurrent depending on the periods in which the temporary differences are expected to reverse. Valuation allowances are established when necessary to reduce the deferred tax assets to the amount expected to be realized. The Company follows the provisions of FASB ASC 740-10 “Uncertainty in Income Taxes” (ASC 740-10). Certain recognition thresholds must be met before a tax position is recognized in the financial statements. An entity may only recognize or continue to recognize tax positions that meet a “more-likely-than-not” threshold. At January 31, 2017 and 2016, the Company does not believe it has any uncertain tax positions that would require either recognition or disclosure in the accompanying financial statements.
Net Loss per Share of Common Stock	Net Loss per Share of Common Stock The Company computes net earnings (loss) per share in accordance with ASC 260-10, “Earnings per Share.” ASC 260-10 requires presentation of both basic and diluted earnings per share (“EPS”) on the face of the income statement. Basic EPS is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period. Diluted EPS gives effect to all dilutive potential common shares outstanding during the period. The Company’s diluted EPS excludes all dilutive potential common shares if their effect is anti-dilutive. At January 31, 2017, there were options to purchase 7,690,000 shares of the Company’s common stock, 10,298,746 warrants to purchase shares of the Company's common stock, 166,667 shares of the Company’s common stock reserved for issuance related to convertible unsecured notes payable and 6,748,354 shares of the Company’s common stock reserved for issuance related to convertible secured notes payable which may dilute future earnings per share.
Related Parties	Related Parties Parties are considered related to the Company if the parties, directly or indirectly, through one or more intermediaries, control, are controlled by, or are under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests. The Company discloses all related party transactions. All transactions are recorded at fair value of the goods or services exchanged.
New Accounting Pronouncements	New Accounting Pronouncements In August 2014, the FASB issued Accounting Standards Update No. 2014-15, Presentation of Financial Statements­ Going Concern (Subtopic 205-40), Disclosure of Uncertainties about an Entities Ability to Continue as a Going Concern (ASU 2014-15). The guidance in ASU 2014-15 sets forth management's responsibility to evaluate whether there is substantial doubt about an entity's ability to continue as a going concern as well as required disclosures. ASU 2014-15 indicates that, when preparing financial statements for interim and annual financial statements, management should evaluate whether conditions or events, in the aggregate, raise substantial doubt about the entity's ability to continue as a going concern for one year from the date the financial statements are issued or are available to be issued. This evaluation should include consideration of conditions and events that are either known or are reasonably knowable at the date the financial statements are issued or are available to be issued, as well as whether it is probable that management's plans to address the substantial doubt will be implemented and, if so, whether it is probable that the plans will alleviate the substantial doubt. ASU 2014-15 is effective for annual periods ending after December 15, 2016, and interim periods and annual periods thereafter. Early application is permitted. The adoption of this guidance is not expected to have a material impact on the Company's unaudited financial statements. The Company has evaluated other recent accounting pronouncements and their adoption, and has not had, and is not expected to have, a material impact on the Company's financial position or results of operations. Other new pronouncements issued but not yet effective until after January 31, 2017 are not expected to have a significant effect on the Company's financial position or results of operations.

NATURE OF OPERATIONS, BASIS O14

NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)	9 Months Ended
	Jan. 31, 2017
Schedule of estimated useful lives	Furniture and fixtures 5 to 7 years Computer and office equipment 3 to 7 years
Summary of Assets and liabilities measured at fair value on a recurring and non-recurring basis	Carrying Value Fair Value Measurements at At January 31, 2017 January 31, 2017 Level 1 Level 2 Level 3 Embedded conversion option liability $ 596,602 $ — $ — $ 596,602
Level 3 [Member]
Summary of Assets and liabilities measured at fair value on a recurring and non-recurring basis	Balance – April 30, 2016 $ 462,531 Loss from change in the fair value of derivative liabilities 285,435 Change in embedded derivative liability for partial conversions of a convertible secured promissory note (151,364 ) Balance – January 31, 2017 $ 596,602

DEBT (Tables)

DEBT (Tables)	9 Months Ended
	Jan. 31, 2017
Schedule of Notes Payable	January 31, 2017 April 30, 2016 Notes Payable: Note payable – January 6, 2016. Interest at 8% and principal payable on demand. $ 100,000 $ 100,000 Note payable – June 6, 2016. Interest at 4% and principal payable on demand. 10,000 — Note payable – August 4, 2016. Interest at 8% and principal payable on demand. 105,000 — Note payable – September 27, 2016. Interest at 4% and principal payable on demand. 30,000 — Note payable – September 29, 2016. Interest at 4% and principal payable on demand. 5,000 — Note payable – September 29, 2016. Interest at 4% and principal payable on demand. 30,000 — Note payable – October 3, 2016. Interest at 4% and principal payable on demand. 20,000 — Total Notes payable $ 300,000 $ 100,000
Schedule of Related Party Notes Payable	January 31, 2017 April 30, 2016 Notes Payable, Related Party: Notes payable, related party. Seven (7) separate loans beginning on February 11, 2015 with last loan on August 28, 2015. No interest and principal payable on demand. $ 15,300 $ 20,300 Total Notes payable, related party $ 15,300 $ 20,300
Schedule of assumptions for note payables	Stock Price (issue date) $ 0.50 Conversion Price $ 0.30 Expected Remaining Term 1 year Volatility 247 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.22 %
Schedule of amount fully paid by borrower	Date of Note Satisfaction Principal Amount of this Note 0 to 30 days after the OID $ 605,000 31 to 60 days after the OID $ 632,500 61 to 90 days after the OID $ 660,000 91 - 120 days after the OID $ 687,500
Secured promissory notes [Member]
Schedule of Notes Payable	January 31, 2017 April 30, 2016 Convertible Secured Note Payable: Secured convertible promissory note payable – issued March 9, 2016 - Interest accrued at 10% and principal and interest due one year from the issuance date. $ 550,000 $ 550,000 Less: conversion of $195,000 of principal to common stock (195,000 ) — Less: debt discount (55,754 ) (471,644 ) Total Convertible Secured Notes Payable, net of debt discount $ 299,246 $ 78,356
Unsecured promissory notes [Member]
Schedule of Notes Payable	January 31, 2017 April 30, 2016 Convertible Unsecured Note Payable: Unsecured convertible promissory note payable – Interest accrued at 5% and principal and interest due 12 months from the issuance date. 50,000 50,000 Less: Debt discount (6,574 ) (31,780 ) Total Convertible Unsecured Note Payable, net of debt discount $ 43,426 $ 18,220

STOCK BASED COMPENSATION (Table

STOCK BASED COMPENSATION (Tables)	9 Months Ended
	Jan. 31, 2017
Schedule of Stock Option Activity	Employee and Consultant Stock Options Outstanding Weighted Weighted Average Average Remaining Aggregate Number of Exercise Contractual Intrinsic Options Price Life (Years) Value Outstanding, April 30, 2016 5,730,000 $ 0.18 7.73 $ 252,280 Issued June 10, 2016 1,910,000 $ 0.31 9.36 — Issued August 4, 2016 50,000 $ 0.30 9.51 — Outstanding, January 31, 2017 7,690,000 $ 0.22 8.14 $ 252,280 Exercisable, January 31, 2017 2,547,500 $ 0.22 7.74 $ 110.373
Schedule of Warrant Activity	Consultant Stock Warrants Outstanding Weighted Weighted Average Average Remaining Aggregate Number of Exercise Contractual Intrinsic Warrants Price Life (Years) Value Outstanding, April 30, 2016 7,193,746 $ 0.24 0.98 $ 310,255 Issued June 10, 2016 2,400,000 $ 0.01 2.35 312,240 Issued August 4, 2016 400,000 $ 0.01 1.50 $ 52,040 Issued January 12, 2017 through January 26, 2017 305,000 $ 1.00 0.95 — Outstanding, January 31, 2017 10,298,746 $ 0.20 1.32 $ 674,535 Exercisable, January 31, 2017 10,298,746 $ 0.20 1.32 $ 674,535
Award Issued One [Member]
Schedule of Fair Value Assumptions Used to Value Stock Options	Stock Price (re-measurement date of January 31, 2017) $ 0.14 Exercise Price $ 0.05 Expected Remaining Term 7.45 years Volatility 181 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.52 %
Schedule of Fair Value Assumptions Used to Value Warrants	Stock Price (grant date) $ 0.42 Exercise Price $ 0.35 Expected Remaining Term 2.33 years Volatility 317 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.30 %
Award Issued Two [Member]
Schedule of Fair Value Assumptions Used to Value Stock Options	Stock Price (grant date) $ 0.47 Exercise Price $ 0.30 Expected Remaining Term 5 years Volatility 246 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.11 %
Schedule of Fair Value Assumptions Used to Value Warrants	Stock Price (re-measurement date of February 28, 2016) $ 1.00 Exercise Price $ 0.35 Expected Remaining Term 1.83 years Volatility 293 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.32 %
Award Issued Three [Member]
Schedule of Fair Value Assumptions Used to Value Stock Options	Stock Price (grant date) $ 0.32 Exercise Price $ 0.31 Expected Remaining Term 10 years Volatility 191 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.27 %
Schedule of Fair Value Assumptions Used to Value Warrants	Stock Price (grant date) $ 32 Exercise Price $ 0.01 Expected Remaining Term 3 years Volatility 191 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.27 %
Award Issued Four [Member]
Schedule of Fair Value Assumptions Used to Value Stock Options	Stock Price (grant date) $ 0.18 Exercise Price $ 0.30 Expected Remaining Term 5 years Volatility 184 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.26 %
Schedule of Fair Value Assumptions Used to Value Warrants	Stock Price (grant date) $ 0.18 Exercise Price $ 0.01 Expected Remaining Term 2 years Volatility 184 % Annual Rate of Quarterly Dividends 0.00 % Risk Free Interest Rate 0.26 %

COMMITMENTS AND CONTINGENCIES (

COMMITMENTS AND CONTINGENCIES (Tables)	9 Months Ended
	Jan. 31, 2017
Commitments and Contingencies Disclosure [Abstract]
Schedule of Minimum Lease Payments	2017 $ 71,508 2018 35,754 Total $ 107,262

NATURE OF OPERATIONS, BASIS O18

NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details)	Jul. 14, 2014shares	Apr. 30, 2016USD ($)	Mar. 31, 2016USD ($)	Jan. 31, 2017USD ($)	Jan. 31, 2016USD ($)	Jan. 31, 2017USD ($)itemshares	Jan. 31, 2016USD ($)
NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Stock issued in exchange for assets of Major League Football, LLC, shares | shares	8,000,000
Number of primary channels | item						3
Number of revenues generated primary channels | item						2
Net loss				$ 1,025,028	$ 1,236,811	$ 4,386,576	$ 3,986,852
Net cash used in operating activities						235,681	803,048
Working capital deficit				4,106,505		4,106,505
Accumulated deficiency		$ 21,121,832		25,508,408		25,508,408
Stockholders' deficiency		1,828,012		4,091,977		4,091,977
Depreciation expense						348	$ 181
Accumulated depreciation				$ 13,940		$ 13,940
Disbursement for loan receivable			$ 125,000
Disbursement for collateral deposit		$ 50,000
Sales Revenue, Net [Member] | Customer Concentration Risk [Member]
NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Concentration percentage						100.00%
Stock Compensation Plan [Member]
NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Antidilutive securities | shares						7,690,000
Warrant [Member]
NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Antidilutive securities | shares						10,298,746
Unsecured promissory notes [Member]
NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Antidilutive securities | shares						166,667
Secured promissory notes [Member]
NATURE OF OPERATIONS, BASIS OF PRESENTATION, GOING CONCERN, AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract]
Antidilutive securities | shares						6,748,354

NATURE OF OPERATIONS AND SUMMAR

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Schedule of Useful Lives of PP&E) (Details)	9 Months Ended
	Jan. 31, 2017
Furniture and fixtures [Member] | Minimum [Member]
Estimated useful life Furniture, Fixtures and Equipment	5 years
Furniture and fixtures [Member] | Maximum [Member]
Estimated useful life Furniture, Fixtures and Equipment	7 years
Computer and office equipment [Member] | Minimum [Member]
Estimated useful life Furniture, Fixtures and Equipment	3 years
Computer and office equipment [Member] | Maximum [Member]
Estimated useful life Furniture, Fixtures and Equipment	7 years

NATURE OF OPERATIONS AND SUMM20

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Assets and Liabilities Measured at Fair Value) (Details) - USD ($)	Jan. 31, 2017	Apr. 30, 2016
Embedded conversion option liability	$ 596,602	$ 462,531
Level 1 [Member]
Embedded conversion option liability
Level 2 [Member]
Embedded conversion option liability
Level 3 [Member]
Embedded conversion option liability	$ 596,602

NATURE OF OPERATIONS AND SUMM21

NATURE OF OPERATIONS AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Activity of Level 3 Assets and Liabilities) (Details)	9 Months Ended
	Jan. 31, 2017USD ($)
Nature Of Operations And Summary Of Significant Accounting Policies Activity Of Level 3 Assets And Liabilities Details
Balance - April 30, 2016	$ 462,531
Loss from change in the fair value of derivative liabilities	285,435
Change in embedded derivative liability for partial conversions of a convertible secured promissory note	(151,364)
Balance - January 31, 2017	$ 596,602

DEBT (Narrative) (Details)

DEBT (Narrative) (Details) - USD ($)	Jan. 31, 2017	Jan. 26, 2017	Jan. 24, 2017	Jan. 23, 2017	Jan. 12, 2017	Jan. 06, 2017	Dec. 29, 2016	Dec. 23, 2016	Dec. 16, 2016	Dec. 13, 2016	Nov. 15, 2016	Nov. 02, 2016	Oct. 31, 2016	Oct. 31, 2016	Oct. 26, 2016	Sep. 30, 2016	Sep. 13, 2016	Sep. 13, 2016	Apr. 14, 2016	Mar. 09, 2016	Mar. 09, 2016	Aug. 28, 2015	Oct. 26, 2016	Oct. 26, 2016	Sep. 30, 2016	Oct. 31, 2015	Jan. 21, 2017	Jan. 31, 2017	Jan. 31, 2016	Oct. 31, 2015	Jan. 31, 2017	Jan. 31, 2016	Mar. 31, 2017	Apr. 30, 2016	Aug. 26, 2015
Debt Instrument [Line Items]
Convertible promissory notes	$ 43,426																											$ 43,426			$ 43,426			$ 18,220
Conversion of debt, financial instrument amount																		$ 15,000						$ 15,000	$ 15,000
Notes payable, net of original issue discount	300,000																											300,000			300,000			100,000
Notes payable, related parties	$ 15,300																											15,300			15,300			20,300
Proceeds from issuance of convertible promissory notes																																$ 214,700
Shares and warrants issued upon conversion of debt																															3,567,177
Interest expense																												165,953	$ 571		$ 495,680	1,053,348
Repayment of notes payable																															25,000
Repayment of fund																														$ 15,000	5,000	15,000
Repayment of note payable by officer personally																						$ 20,000
Excercise Price															$ 0.15	$ 0.17	$ 0.18	$ 0.18					$ 0.15	$ 0.15	$ 0.17
Embedded conversion option liability													$ 358,230	$ 358,230																				462,531
Income (expenses) recorded for change in fair value of embedded conversion option liability													27,299															$ (351,196)			(285,435)
Amortization of debt discount																															$ 415,890
Warrant Series A [Member]
Debt Instrument [Line Items]
Warrant exercise price	$ 1.02																											$ 1.02			$ 1.02
Term of warrant																															3 years
Acquisition of common stock, shares	250,000																											250,000			250,000
Warrant Series B [Member]
Debt Instrument [Line Items]
Warrant exercise price	$ 1.19																											$ 1.19			$ 1.19
Term of warrant																															3 years
Acquisition of common stock, shares	250,000																											250,000			250,000
Notes Payable Related Party - two [Member]
Debt Instrument [Line Items]
Notes payable, related parties	$ 15,300																											$ 15,300			$ 15,300			20,300
Repayment of fund																												5,000
Convertible Debt [Member]
Debt Instrument [Line Items]
Debt instrument, conversion price (dollars per share)																										$ 0.30				$ 0.30
Shares and warrants issued upon conversion of debt																										2,330,327
Stock price																			$ 0.50
Excercise Price																			$ 0.30
Unsecured Note Payable [Member]
Debt Instrument [Line Items]
Notes payable, gross	50,000																											50,000			50,000			50,000
Debt discount	(6,574)																											(6,574)			(6,574)			(31,780)
Convertible promissory notes	$ 43,426																											$ 43,426			$ 43,426			18,220
Debt instrument, interest rate	5.00%																											5.00%			5.00%
Proceeds from issuance of convertible promissory notes																			$ 50,000
Debt instrument, conversion price (dollars per share)	$ 0.30																											$ 0.30			$ 0.30
Accrued interest	$ 2,006																											$ 2,006			$ 2,006
Shares issued upon conversion of debt																			166,667
Interest expense																															25,206
Beneficial conversion feature																			$ 33,333
Expected term																			1 year
Expected volatility																			247.00%
Annual Rate of Quarterly Dividends																			0.00%
Risk Free Interest Rate																			0.22%
Secured Convertible Promissory Note [Member]
Debt Instrument [Line Items]
Notes payable, gross	550,000																											550,000			550,000			550,000
Debt discount	(55,754)																											(55,754)			(55,754)			(471,644)
Conversion of debt, debt amount																															(195,000)
Conversion of debt, financial instrument amount																															195,000
Notes payable, net of original issue discount	$ 299,246																											$ 299,246			$ 299,246			78,356
Shares of common stock under collateral securities	2,000,000																											2,000,000			2,000,000
Officer [Member]
Debt Instrument [Line Items]
Notes payable, related parties																																			$ 300
Repayment of fund																														$ 15,000
Repayment of note payable by officer personally																						$ 20,000
January 6, 2016 Promissory Note [Member]
Debt Instrument [Line Items]
Notes payable, net of original issue discount	$ 100,000																											$ 100,000			$ 100,000			100,000
Debt instrument, interest rate	8.00%																											8.00%			8.00%
Accrued interest	$ 6,709																											$ 6,709			$ 6,709
June 6, 2016 Promissory Note [Member]
Debt Instrument [Line Items]
Notes payable, net of original issue discount	$ 10,000																											$ 10,000			$ 10,000
Debt instrument, interest rate	4.00%																											4.00%			4.00%			4.00%
Accrued interest	$ 263																											$ 263			$ 263
August 4, 2016 Promissory Note [Member]
Debt Instrument [Line Items]
Notes payable, net of original issue discount	105,000																											105,000			105,000
Debt instrument, face amount	$ 130,000																											$ 130,000			$ 130,000
Debt instrument, interest rate	8.00%																											8.00%			8.00%
Accrued interest	$ 5,124																											$ 5,124			$ 5,124
Repayment of notes payable		$ 25,000
September 27, 2016 Promissory Note [Member]
Debt Instrument [Line Items]
Notes payable, net of original issue discount	$ 30,000																											$ 30,000			$ 30,000
Debt instrument, interest rate	4.00%																											4.00%			4.00%
Accrued interest	$ 418																											$ 418			$ 418
September 29, 2016 Promissory Note [Member]
Debt Instrument [Line Items]
Notes payable, net of original issue discount	$ 5,000																											$ 5,000			$ 5,000
Debt instrument, interest rate	4.00%																											4.00%			4.00%
Accrued interest	$ 68																											$ 68			$ 68
September 29, 2016 Promissory Note [Member]
Debt Instrument [Line Items]
Notes payable, net of original issue discount	$ 30,000																											$ 30,000			$ 30,000
Debt instrument, interest rate	4.00%																											4.00%			4.00%
Accrued interest	$ 411																											$ 411			$ 411
October 3, 2016 Promissory Note [Member]
Debt Instrument [Line Items]
Notes payable, net of original issue discount	$ 20,000																											$ 20,000			$ 20,000
Debt instrument, interest rate	4.00%																											4.00%			4.00%
Accrued interest	$ 263																											$ 263			$ 263
Secured Promissory Note Dated March 9 [Member] | Convertible Debt [Member]
Debt Instrument [Line Items]
Convertible promissory notes	355,000												$ 505,000	$ 505,000														355,000			355,000		$ 355,000
Conversion of debt, debt amount															$ 15,000	$ 15,000	$ 15,000						$ 45,000				$ 150,000
Debt instrument, term																					1 year
Proceeds from issuance of convertible promissory notes																					$ 445,000
Debt instrument, conversion price (dollars per share)			$ 0.12	$ 0.08	$ 0.10	$ 0.10	$ 0.12	$ 0.13	$ 0.17	$ 0.14	$ 0.17	$ 0.21			$ 0.15	$ 0.17	$ 0.18	0.18					$ 0.15	0.15	0.17
Accrued interest	$ 48,084																											$ 48,084			$ 48,084
Note convertible into shares of the Common Stock rate																					70.00%
Number of trading days																					20 days
Stock price	$ 0.14		0.12	0.08	0.10	0.10	0.12	0.13	0.17	0.14	0.17	0.21	$ 0.20	$ 0.20	0.22	0.24	0.29	0.29					0.22	0.22	0.24			$ 0.14			$ 0.14
Excercise Price	$ 0.05		$ 0.05	$ 0.06	$ 0.07	$ 0.07	$ 0.08	$ 0.09	$ 0.09	$ 0.10	$ 0.12	$ 0.14	$ 0.14	$ 0.14	$ 0.15	$ 0.17	$ 0.18	$ 0.18					$ 0.15	$ 0.15	$ 0.17			$ 0.05			$ 0.05
Expected term	1 month 6 days		1 month 13 days	1 month 13 days	1 month 24 days	2 months 1 day	2 months 9 days	2 months 16 days	2 months 23 days	2 months 27 days	3 months 22 days	4 months 6 days		4 months 6 days	4 months 13 days	5 months 9 days	5 months 23 days				1 year
Expected volatility	181.00%		179.00%	179.00%	173.00%	174.00%	176.00%	176.00%	175.00%	175.00%	177.00%	175.00%		175.00%	179.00%	175.00%	181.00%				247.00%
Discount rate	0.52%		0.50%	0.51%	0.51%	0.52%	0.46%	0.51%	0.50%	0.54%	0.50%	0.36%		0.20%	0.25%	0.20%	0.25%				0.03%
Assumed number of shares issued	6,748,354		7,108,836	6,553,350	5,851,953	5,551,213	4,941,867	4,924,539	4,718,254	4,655,067	3,924,206	3,500,000		3,567,177	3,496,593	3,240,318	3,142,857				1,161,972
Fair value of warrant																					$ 239,069
Original issue discount																					$ 50,000
Embedded conversion option liability	$ 596,602		$ 497,281	$ 186,323	$ 242,909	$ 251,876	$ 260,433	$ 295,424	$ 431,000	$ 297,684	$ 328,745	$ 380,511			$ 385,429	$ 410,038	$ 544,400	$ 544,400					$ 385,429	$ 385,429	$ 410,038			$ 596,602			$ 596,602
Amortization period																					1 year
Reclassification of embedded conversion option liability to additional paid in capital																							38,540				112,824
Income (expenses) recorded for change in fair value of embedded conversion option liability	$ (99,321)																				$ (723,646)		$ (139,642)				$ (139,051)
Secured Promissory Note Dated March 9 [Member] | Convertible Debt [Member] | Warrant Series A [Member]
Debt Instrument [Line Items]
Stock price																				$ 0.93	$ 0.93
Excercise Price																				1.02	1.02
Secured Promissory Note Dated March 9 [Member] | Convertible Debt [Member] | Warrant Series B [Member]
Debt Instrument [Line Items]
Excercise Price																				$ 1.19	$ 1.19
Secured Promissory Note Dated March 9 [Member] | Convertible Debt [Member] | Warrant Series A and B [Member]
Debt Instrument [Line Items]
Expected term																				3 years
Expected volatility																				287.00%
Discount rate																				30.00%
Secured Promissory Note Dated March 9 [Member] | Convertible Debt [Member] | Minimum [Member] | Default Scenario [Member]
Debt Instrument [Line Items]
Debt instrument, interest rate																				22.00%	22.00%
Stock price																				$ 0.93	$ 0.93
Secured Promissory Note Dated March 9 [Member] | Secured promissory notes [Member]
Debt Instrument [Line Items]
Debt discount																				$ (50,000)	$ (50,000)
Debt instrument, face amount																				$ 550,000	$ 550,000
Debt instrument, interest rate																				10.00%	10.00%
Debt issuance cost																				$ 55,000	$ 55,000
Derivative liability																				$ 929,577	$ 929,577
Excercise Price																				$ 0.47	$ 0.47
Embedded conversion option liability																				$ 205,931	$ 205,931

DEBT (Schedule of Principal Adj

DEBT (Schedule of Principal Adjustments For Note Prepayment) (Details) - Secured Promissory Note Dated March 9 [Member]	9 Months Ended
	Jan. 31, 2017USD ($)
0 to 30 days [Member]
Principal amount of this note	$ 605,000
31 to 60 days [Member]
Principal amount of this note	632,500
61 to 90 days [Member]
Principal amount of this note	660,000
91 - 120 days [Member]
Principal amount of this note	$ 687,500

STOCK BASED COMPENSATION (Stock

STOCK BASED COMPENSATION (Stock Options Narrative) (Details) - USD ($)	Jan. 26, 2017	Aug. 04, 2016	Jun. 10, 2016	Sep. 30, 2015	Aug. 28, 2015	Feb. 24, 2015	Jul. 14, 2014	Jan. 31, 2017	Feb. 28, 2016	Aug. 28, 2015	Jan. 31, 2015	Dec. 31, 2014	Jan. 31, 2017	Jan. 31, 2016	Apr. 30, 2016	Mar. 10, 2016	Oct. 31, 2015	Apr. 30, 2015	Feb. 28, 2015	Nov. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding								7,690,000					7,690,000		5,730,000
Stock options granted		50,000	1,910,000
Share-based compensation
Option exercised				10,000
Exercise price		$ 0.30	$ 0.31					$ 0.10
Vested option outstanding								2,547,500					2,547,500
Unvested option outstanding								2,070,000					2,070,000
Unvested option outstanding, fair value								$ 1,090,400					$ 1,090,400
Consulting expense													221,966		458,855
Prepaid balance of stock warrants								0					$ 0		221,966
Private placement offering								$ 400,000
Number of share of common stock in each unit								500,000					500,000
Exercise price of warrants								$ 1
Proceeds from the offering under private placement								$ 61,000
Number of shares of stock under private placement								610,000
Number of warrants under private placement								250,000					250,000
Proceeds allocated to shares of stock								$ 61,000					$ 61,000	$ 469,450	$ 554,450
Proceeds allocated to warrants								5,194
Proceeds from issuance of units								$ 55,806
Warrants exercised				100,000				305,000
Cash proceeds from exercise of warrants														1,000
Stock option exercise price (in dollars per share)				$ 0.30
Proceeds from exercise of stock options				$ 3,000										$ 3,000
Warrants exercise price (in dollars per share)				$ 0.01
Proceeds from exercise of stock warrants				$ 1,000
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding								10,298,746					10,298,746		7,193,746			850,000
Stock options granted	305,000	400,000	2,400,000
Vesting period													2 years
Exercise price	$ 1	$ 0.01	$ 0.01		$ 0.35				$ 0.35	$ 0.35					$ 0.35
Vested option outstanding								10,298,746					10,298,746
Consulting expense													$ 69,741
Share Price					$ 0.42				$ 1	$ 0.42
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price						$ 0.30							$ 0.05		$ 0.05
Share Price						$ 0.47		$ 0.14					$ 0.14
Employees [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price		0.30
Share Price		$ 0.18
Five Employees [Member] | Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price			0.31
Share Price			$ 0.32
Professionals And Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation							$ 132,482
Six Consultants [Member] | Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period			3 years
Exercise price			$ 0.01
Fair value			$ 758,808
Share Price			$ 0.32
Vesting Immediately [Member] | Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation										$ 400,000
Exercise price										$ 0.35
Fair value					$ 289,867					$ 289,867
Vested immediately					700,000					700,000
Warrants granted to purchase common stock					1,400,000					1,400,000
Consulting expense										$ 94,505
Prepaid balance of stock warrants					$ 0					0
Share-based Compensation Award, Tranche Three [Member] | Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted															400,000
Share-based compensation													$ 54,773
Fair value															$ 168,000
Consulting expense															113,227
Prepaid balance of stock warrants								$ 0					$ 0
Amortized consulting expense															168,000
Remaining unamortized amount															$ 54,773
Share-based Compensation Award, Tranche Two [Member] | Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted					700,000
Vesting period					6 months
Fair value					$ 289,867					$ 289,867									$ 289,867
Prepaid balance of stock warrants																			$ 221,966
Unvested stock warrants																			700,000
Warrants adjusted valuation amount									$ 680,821
2006 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized under plan								400,000					400,000
Award expiration period													10 years
Stock options outstanding								40,000					40,000
2014 Employee Stock Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized under plan								10,000,000					10,000,000
Award expiration period													10 years
2014 Employee Stock Plan [Member] | Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation													$ 1,738
2014 Employee Stock Plan [Member] | July 2014 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding																	800,000
Stock options granted							4,150,000
Option exercised											300,000
Exercise price							$ 0.05
2014 Employee Stock Plan [Member] | July 2014 [Member] | Vesting Immediately [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted							1,100,000
Share-based compensation							$ 55,000
2014 Employee Stock Plan [Member] | July 2014 [Member] | Share-based Compensation Award, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding																				3,050,000
Stock options granted							3,050,000								2,000,000
Share-based compensation															$ 250,518
Option cancelled												1,050,000
2014 Employee Stock Plan [Member] | July 2014 [Member] | Share-based Compensation Award, Tranche Three [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							4 years
2014 Employee Stock Plan [Member] | July 2014 [Member] | Share-based Compensation Award, Tranche Three [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period							3 years
2014 Employee Stock Plan [Member] | February 2015 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted						5,900,000
2014 Employee Stock Plan [Member] | February 2015 [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted						2,900,000
Vesting period						4 years
Exercise price						$ 0.30
2014 Employee Stock Plan [Member] | February 2015 [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted						3,000,000
Vesting period						2 years
Exercise price						$ 0.30
Vested option outstanding								1,281,250					1,281,250
Vested immediately								250,000					250,000
Options vested as per above								1,031,250					1,031,250
Vested options expired																1,281,250
2014 Employee Stock Plan [Member] | February 2015 [Member] | Five Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted			1,910,000
Exercise price			$ 0.31
2014 Employee Stock Plan [Member] | February 2015 [Member] | Vesting Immediately [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted						830,000
Share-based compensation						$ 390,100
2014 Employee Stock Plan [Member] | February 2015 [Member] | Vesting Immediately [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted						580,000
2014 Employee Stock Plan [Member] | February 2015 [Member] | Vesting Immediately [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted						250,000
2014 Employee Stock Plan [Member] | February 2015 [Member] | Vesting Immediately [Member] | Five Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted			102,500
Share-based compensation			$ 32,717										$ 499,946
Fair value			$ 576,944
2014 Employee Stock Plan [Member] | February 2015 [Member] | Share-based Compensation Award, Tranche Three [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding								2,000,000					2,000,000
Share-based compensation													$ 171,301
Fair value								$ 87,256					87,256
2014 Employee Stock Plan [Member] | February 2015 [Member] | Share-based Compensation Award, Tranche Three [Member] | Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period						4 years
2014 Employee Stock Plan [Member] | February 2015 [Member] | Share-based Compensation Award, Tranche Three [Member] | Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period						2 years
2014 Employee Stock Plan [Member] | February 2015 [Member] | Share-based Compensation Award, Tranche Three [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted						2,750,000
2014 Employee Stock Plan [Member] | February 2015 [Member] | Share-based Compensation Award, Tranche Two [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted						343,750
2014 Employee Stock Plan [Member] | February 2015 [Member] | Share-based Compensation Award, Tranche Two [Member] | Five Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted			1,807,500
Share-based compensation													$ 4,661
Vesting period			3 years
2014 Employee Stock Plan [Member] | February 2015 [Member] | Share Based Compensation Award Tranche Four [Member] | Chief Executive Officer [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted						343,750
2014 Employee Stock Plan [Member] | On August 4, 2016 [Member] | Employee [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options granted		50,000
Share-based compensation		$ 3,418
Options expired period		Aug. 3, 2026
Vesting period		3 years
Exercise price		$ 0.30
Unvested option outstanding								30,000					30,000
Unvested option outstanding, fair value								$ 5,233					$ 5,233
Vested immediately		20,000						20,000					20,000

STOCK BASED COMPENSATION (Sched

STOCK BASED COMPENSATION (Schedule of Valuation Assumptions Used to Value Stock Options and Warrants) (Details) - $ / shares	Jan. 26, 2017	Aug. 04, 2016	Jun. 10, 2016	Aug. 28, 2015	Feb. 24, 2015	Jan. 31, 2017	Feb. 28, 2016	Aug. 28, 2015	Jan. 31, 2017	Apr. 30, 2016	May 04, 2016	Oct. 15, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Exercise price		$ 0.30	$ 0.31			$ 0.10
Consultant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Price											$ 0.45	$ 1
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Price					$ 0.47	$ 0.14			$ 0.14
Exercise price					$ 0.30				$ 0.05	$ 0.05
Expected Remaining Term					5 years				7 years 5 months 12 days
Volatility					246.00%				181.00%
Annual Rate of Quarterly Dividends					0.00%				0.00%
Risk Free Interest Rate					0.11%				0.52%
Employee Stock Option [Member] | Five Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Price			0.32
Exercise price			$ 0.31
Expected Remaining Term			10 years
Volatility			191.00%
Annual Rate of Quarterly Dividends			0.00%
Risk Free Interest Rate			0.27%
Employee Stock Option [Member] | Employees [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Price		0.18
Exercise price		$ 0.30
Expected Remaining Term		5 years
Volatility		184.00%
Annual Rate of Quarterly Dividends		0.00%
Risk Free Interest Rate		0.26%
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Price				$ 0.42			$ 1	$ 0.42
Exercise price	$ 1	$ 0.01	$ 0.01	$ 0.35			$ 0.35	$ 0.35		$ 0.35
Expected Remaining Term							1 year 9 months 29 days	2 years 3 months 29 days
Volatility							293.00%	317.00%
Annual Rate of Quarterly Dividends							0.00%	0.00%
Risk Free Interest Rate							0.32%	0.30%
Warrant [Member] | Six Consultants [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Price			0.32
Exercise price			$ 0.01
Expected Remaining Term			3 years
Volatility			191.00%
Annual Rate of Quarterly Dividends			0.00%
Risk Free Interest Rate			0.27%
Warrant [Member] | Consultant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock Price		0.18
Exercise price		$ 0.01
Expected Remaining Term		2 years
Volatility		184.00%
Annual Rate of Quarterly Dividends		0.00%
Risk Free Interest Rate		0.26%

STOCK BASED COMPENSATION (Sch26

STOCK BASED COMPENSATION (Schedule of Stock Option Activity) (Details) - USD ($)	Aug. 04, 2016	Jun. 10, 2016	Jan. 31, 2017	Jan. 31, 2017	Apr. 30, 2016
Number of Options
Outstanding, beginning				5,730,000
Issued	50,000	1,910,000
Outstanding, ending			7,690,000	7,690,000	5,730,000
Exercisable			2,547,500	2,547,500
Weighted Average Exercise Price
Outstanding, beginning				$ 0.18
Issued	$ 0.30	$ 0.31	$ 0.10
Outstanding, ending			0.22	0.22	$ 0.18
Exercisable			$ 0.22	$ 0.22
Weighted Average Remaining Contractual Life
Outstanding				8 years 1 month 21 days	7 years 8 months 23 days
Issued	9 years 6 months 4 days	9 years 4 months 10 days
Exercisable				7 years 8 months 27 days
Aggregate intrinsic value, outstanding				$ 252,280
Issued
Aggregate intrinsic value, outstanding			$ 252,280	252,280	$ 252,280
Aggregate intrinsic value, exercisable			$ 110,373	$ 110,373

STOCK BASED COMPENSATION (Sto27

STOCK BASED COMPENSATION (Stock Warrants) (Details) - USD ($)	Jan. 26, 2017	Aug. 04, 2016	Jun. 10, 2016	Sep. 30, 2015	Aug. 28, 2015	Jan. 31, 2017	Feb. 28, 2016	Aug. 28, 2015	Jan. 31, 2017	Apr. 30, 2016
Number of Warrants
Outstanding, beginning									5,730,000
Issued		50,000	1,910,000
Exercised				10,000
Outstanding, ending						7,690,000			7,690,000	5,730,000
Exercisable						2,547,500			2,547,500
Weighted Average Exercise Price
Outstanding, beginning									$ 0.18
Issued		$ 0.30	$ 0.31			$ 0.10
Exercised				$ 0.30
Outstanding, ending						0.22			0.22	$ 0.18
Exercisable						$ 0.22			$ 0.22
Weighted Average Remaining Contractual Life
Weighted-average remaining contractual life outstanding									8 years 1 month 21 days	7 years 8 months 23 days
Aggregate intrinsic value, outstanding									$ 252,280
Issued
Aggregate intrinsic value, outstanding						$ 252,280			252,280	$ 252,280
Aggregate intrinsic value, exercisable						$ 110,373			$ 110,373
Warrant [Member]
Number of Warrants
Outstanding, beginning									7,193,746	850,000
Issued	305,000	400,000	2,400,000
Outstanding, ending						10,298,746			10,298,746	7,193,746
Exercisable						10,298,746			10,298,746
Weighted Average Exercise Price
Outstanding, beginning									$ 0.24	$ 0.01
Issued	$ 1	$ 0.01	$ 0.01		$ 0.35		$ 0.35	$ 0.35		0.35
Outstanding, ending						$ 0.20			0.20	$ 0.24
Exercisable						$ 0.20			$ 0.20
Weighted Average Remaining Contractual Life
Weighted-average remaining contractual life outstanding									1 year 3 months 26 days	11 months 23 days
Weighted-average remaining contractual life issued during period	11 months 12 days	1 year 6 months	2 years 4 months 6 days
Weighted-average remaining contractual life outstanding, Exercisable									1 year 3 months 26 days
Aggregate intrinsic value, outstanding									$ 310,255	$ 690,000
Issued		$ 52,040	$ 312,240
Aggregate intrinsic value, outstanding						$ 674,535			674,535	$ 310,255
Aggregate intrinsic value, exercisable						$ 674,535			$ 674,535

COMMON STOCK (Details)

COMMON STOCK (Details) - USD ($)	Oct. 26, 2016	Sep. 30, 2016	Sep. 13, 2016	Sep. 13, 2016	Aug. 05, 2016	Aug. 04, 2016	Jun. 10, 2016	May 04, 2016	Dec. 08, 2015	Oct. 15, 2015	Sep. 30, 2015	Mar. 23, 2015	Jul. 14, 2014	Jan. 31, 2017	Oct. 26, 2016	Oct. 26, 2016	Sep. 30, 2016	Jun. 10, 2016	Oct. 31, 2015	Jan. 21, 2017	Jan. 31, 2017	Jan. 31, 2016	Jan. 31, 2017	Jan. 31, 2016	Apr. 30, 2016	Mar. 31, 2017	Jan. 24, 2017	Jan. 23, 2017	Jan. 12, 2017	Jan. 06, 2017	Dec. 29, 2016	Dec. 23, 2016	Dec. 16, 2016	Dec. 13, 2016	Nov. 15, 2016	Nov. 02, 2016	Oct. 31, 2016	Aug. 31, 2016	Apr. 14, 2016	Jan. 14, 2016	Jan. 01, 2016
Class of Stock [Line Items]
Preferred stock, shares issued														0							0		0		0
Preferred stock, shares outstanding														0							0		0		0
Common stock, shares authorized														150,000,000							150,000,000		150,000,000		150,000,000
Common stock, par value														$ 0.001							$ 0.001		$ 0.001		$ 0.001
Common stock, shares issued														48,967,203							48,967,203		48,967,203		41,013,077
Common stock, shares outstanding														48,967,203							48,967,203		48,967,203		41,013,077
Number of shares of unvested common stock to be issued to employees over the vesting period of four years through July 14, 2018														1,500,000							1,500,000		1,500,000
Number of shares of unvested common stock to be issued to employees over the vesting period of four years through July 14, 2018 having no voting rights														1,500,000							1,500,000		1,500,000
Unvested option outstanding														2,070,000							2,070,000		2,070,000
Unvested option outstanding, fair value														$ 1,090,400							$ 1,090,400		$ 1,090,400
Debt conversion amount				$ 15,000												$ 15,000	$ 15,000
Notes principal balance	$ 550,000													$ 505,000	$ 550,000	$ 550,000					$ 505,000		$ 505,000
Percentage of conversion price														70.00%							70.00%		70.00%
Stock based compensation expense
Stock options granted						50,000	1,910,000
Gain on the settlement of debt																								$ 84,580
Damages awarded in litigation matter from Consent of Judgement					$ 100,000
Option exercised											(10,000)
Other Prepaid Expense, Current														$ 11,094							11,094		11,094		650,853
Consulting expense																					110,120	$ 593,750	1,718,750	1,027,006
Prepaid Consulting - Current														0							0		$ 0
Shares and warrants issued upon conversion of debt																							3,567,177
Warrants exercise price (in dollars per share)											$ 0.01
Proceeds from exercise of stock warrants											$ 1,000
Stock option exercise price (in dollars per share)											$ 0.30
Proceeds from exercise of stock options											$ 3,000													3,000
Conversion price assumed	$ 0.15	$ 0.17	$ 0.18	$ 0.18											$ 0.15	$ 0.15	$ 0.17
Proceeds from a private placement offering														$ 61,000
Number of shares of stock under private placement														610,000
Proceeds allocated to shares of stock														$ 61,000									61,000	$ 469,450	554,450
Proceeds allocated to warrants														$ 5,194
Exercise price of warrants														$ 1
Exercise warrants											100,000			305,000
Convertible promissory notes														$ 43,426							$ 43,426		$ 43,426		$ 18,220
Proceeds from issuance of units														$ 55,806
2014 Employee Stock Plan [Member]
Class of Stock [Line Items]
Common shares issued																27,000
Shares authorized under plan														10,000,000							10,000,000		10,000,000
2014 Employee Stock Plan [Member]
Class of Stock [Line Items]
Stock based compensation expense																		$ 66,062
Shares authorized under plan							8,690,000											8,690,000
Stock options granted																		160,132
2014 Employee Stock Plan [Member] | Minimum [Member]
Class of Stock [Line Items]
Stock Price							$ 0.32											$ 0.32
2014 Employee Stock Plan [Member] | Maximum [Member]
Class of Stock [Line Items]
Stock Price							$ 0.51											$ 0.51
Convertible Debt [Member]
Class of Stock [Line Items]
Stock Price																																							$ 0.50
Shares and warrants issued upon conversion of debt																			2,330,327
Conversion price assumed																																							$ 0.30
Debt instrument, conversion price (dollars per share)																			$ 0.30
Convertible Debt [Member] | Secured Promissory Note Dated March 9 [Member]
Class of Stock [Line Items]
Stock Price	0.22	0.24	0.29	0.29										$ 0.14	0.22	$ 0.22	0.24				$ 0.14		$ 0.14				$ 0.12	$ 0.08	$ 0.10	$ 0.10	$ 0.12	$ 0.13	$ 0.17	$ 0.14	$ 0.17	$ 0.21	$ 0.20
Conversion price assumed	0.15	0.17	0.18	0.18										$ 0.05	0.15	0.15	0.17				$ 0.05		$ 0.05				0.05	0.06	0.07	0.07	0.08	0.09	0.09	0.10	0.12	0.14	$ 0.14
Debt instrument, conversion price (dollars per share)	$ 0.15	$ 0.17	$ 0.18	$ 0.18											$ 0.15	$ 0.15	$ 0.17										$ 0.12	$ 0.08	$ 0.10	$ 0.10	$ 0.12	$ 0.13	$ 0.17	$ 0.14	$ 0.17	$ 0.21
Conversion of debt, debt amount	$ 15,000	$ 15,000	$ 15,000												$ 45,000					$ 150,000
Convertible promissory notes														$ 355,000							$ 355,000		$ 355,000			$ 355,000											$ 505,000
March Consultant [Member]
Class of Stock [Line Items]
Stock issued as compensation for service, shares												500,000
Stock Price												$ 0.30
Issuance of common stock for employee services - $0.05 per share												$ 150,000
Term of agreement with investor relations firm as a consultant												2 years
Value of common stock to consultant for professional services												$ 150,000
Consulting expense																							56,250
Prepaid Consulting - Current														$ 10,736							$ 10,736		10,736
Consultant [Member]
Class of Stock [Line Items]
Stock based compensation expense								$ 41,337
Stock issued as compensation for service, shares									500,000	112,500
Stock options granted								91,860
Stock Price								$ 0.45		$ 1
Issuance of common stock for employee services - $0.05 per share									$ 275,000	$ 112,500
Term of agreement with investor relations firm as a consultant									6 months	1 year
Value of common stock to consultant for professional services									$ 275,000	$ 112,500
Other Prepaid Expense, Current																																								$ 32,527	$ 72,000
Consulting expense																							55,907
Warrants exercised (in shares)						1,300,000
Warrants exercise price (in dollars per share)						$ 0.01
Proceeds from exercise of stock warrants						$ 13,000
October Consultant [Member]
Class of Stock [Line Items]
Consulting expense																							$ 51,111
Lender [Member]
Class of Stock [Line Items]
Common shares issued																							278,504
Employee [Member] | 2014 Employee Stock Plan [Member]
Class of Stock [Line Items]
Common shares issued																8,690,000
Common shares issued, value																$ 5,940
Stock based compensation expense																							$ 1,738
Equity issuance, price per share	$ 0.22														$ 0.22	$ 0.22
Management [Member]
Class of Stock [Line Items]
Common stock issued as share based compensation													19,000,000
Unvested option outstanding														1,500,000							1,500,000		1,500,000															2,000,000
Vested shares														5,500,000							5,500,000		5,500,000
Management [Member] | Vesting Immediately [Member]
Class of Stock [Line Items]
Stock based compensation expense																							$ 138,494
Stock issued as compensation for service, shares													12,000,000										0	3,500,000
Management [Member] | Share-based Compensation Award, Tranche Two [Member]
Class of Stock [Line Items]
Stock issued as compensation for service, shares													7,000,000
Original Unvested Shares [Member]
Class of Stock [Line Items]
Unvested option outstanding														7,000,000							7,000,000		7,000,000
Unvested option outstanding, fair value														$ 350,000							$ 350,000		$ 350,000
Unvested option outstanding, price per share														$ 0.05							$ 0.05		$ 0.05

RELATED PARTY TRANSACTIONS (Det

RELATED PARTY TRANSACTIONS (Details) - USD ($)	Aug. 28, 2015	Oct. 31, 2015	Jul. 31, 2015	Aug. 31, 2015	Jan. 31, 2017	Jan. 31, 2016	Apr. 30, 2016	Aug. 26, 2015
Related Party Transaction [Line Items]
Accrued officers' compensation					$ 1,635,000		$ 960,000
Accrued officer payroll taxes					91,039		50,841
Proceeds from issuance of notes payable - related parties			$ 15,300	$ 15,300		$ 21,300
Increase in payroll taxes					40,198
Repayment of notes payable to related parties		$ 15,000			5,000	$ 15,000
Repayment of note payable by officer personally	$ 20,000
Notes payable, related parties					15,300		$ 20,300
Outstanding balance					300
Management [Member]
Related Party Transaction [Line Items]
Officers' compensation expense					675,000
Accrued officers' compensation					1,635,000
Officer [Member]
Related Party Transaction [Line Items]
Proceeds from issuance of notes payable - related parties					$ 6,646
Repayment of notes payable to related parties		$ 15,000
Repayment of note payable by officer personally	$ 20,000
Notes payable, related parties								$ 300

COMMITMENTS AND CONTINGENCIES30

COMMITMENTS AND CONTINGENCIES (Future Minimum Lease Payments) (Details)	Jan. 31, 2017USD ($)
Lease:
2,017	$ 71,508
2,018	35,754
Total	$ 107,262

COMMITMENTS AND CONTINGENCIES31

COMMITMENTS AND CONTINGENCIES (Narrative) (Details)	Oct. 04, 2016USD ($)	Aug. 05, 2016USD ($)	Jun. 02, 2016USD ($)	Nov. 12, 2015USD ($)	Jul. 14, 2014USD ($)$ / sharesshares	Jan. 31, 2017USD ($)	Oct. 31, 2016USD ($)	Nov. 30, 2015USD ($)	Sep. 30, 2015USD ($)item	Jan. 31, 2017USD ($)	Jan. 31, 2016USD ($)	Jan. 31, 2017USD ($)	Jan. 31, 2016USD ($)	Apr. 30, 2016USD ($)	Feb. 05, 2016USD ($)
Loss Contingencies [Line Items]
Damages awarded in litigation matter from Consent of Judgement		$ 100,000
Settlement amount		98,173
Processing fee						$ 8				$ 8		$ 8
Rent deposit						11,918				11,918		11,918		$ 11,918
State income taxes payable						110,154				110,154		110,154		110,154
Accrual for taxes, penalties and interest owed to IRS and the State of Delaware from the tax year ending April 30, 2007						177,717				177,717		177,717
Gain on settlement													$ 84,580
Unpaid lease payments												58,000
Lawsuit claim amount		398,173
Settlement of lawsuit paid		100,000
Legal fees		$ 3,699
Prepaid legal						7,500				7,500		7,500
Private placement offering						400,000
Advances						61,000				61,000		61,000
Accrued income taxes						$ 1,764				$ 1,764		1,764
Clairemont Private Investment Group, LLC [Member]
Loss Contingencies [Line Items]
Common stock sale and purchase default payment by related party															$ 20,000,000
Internal Revenue Service (IRS) [Member]
Loss Contingencies [Line Items]
Settlement amount												$ 13,785
Payment upon the execution of settlement				$ 2,757				$ 2,757	$ 1,000
Payment of settlement				$ 1,757				$ 1,757
Percentage of down payment on settlement amount				20.00%			20.00%	20.00%
Payment of second installment of settlement									2,208
Payment of monthly installment of settlement							$ 2,205		$ 2,205
Application fee for OIC							186
Remaining Orignal OIC payment							$ 449
Number of installment in which settlement to be paid | item									4
H&J Ventures, LLC Claim [Member] | Pending Litigation [Member]
Loss Contingencies [Line Items]
Lawsuit claim amount	$ 7,800,000
Settlement sought	$ 6,630,000
Notice of Default [Member]
Loss Contingencies [Line Items]
Unpaid lease payments			$ 57,857
Accelerated rent			224,596
Lawsuit claim amount			$ 282,453
Law Firm Having Consent Of Judgement Against Company [Member] | Pending Litigation [Member]
Loss Contingencies [Line Items]
Damages awarded in litigation matter from Consent of Judgement					$ 166,129
Share Price | $ / shares					$ 0.05
Stock issued as compensation for service, shares | shares					100,000
Settlement of lawsuit paid					$ 166,129

SUBSEQUENT EVENTS (Details)

SUBSEQUENT EVENTS (Details) - USD ($)	Mar. 14, 2017	Mar. 08, 2017	Mar. 06, 2017	Mar. 03, 2017	Mar. 02, 2017	Feb. 23, 2017	Feb. 17, 2017	Feb. 14, 2017	Feb. 08, 2017	Feb. 06, 2017	Feb. 02, 2017	Jan. 31, 2017	Jan. 26, 2017	Jan. 24, 2017	Jan. 23, 2017	Jan. 12, 2017	Jan. 06, 2017	Dec. 29, 2016	Dec. 23, 2016	Dec. 16, 2016	Dec. 13, 2016	Nov. 15, 2016	Nov. 02, 2016	Oct. 31, 2016	Oct. 26, 2016	Sep. 30, 2016	Sep. 13, 2016	Sep. 13, 2016	Mar. 09, 2016	Sep. 30, 2015	Mar. 14, 2017	Mar. 08, 2017	Mar. 03, 2017	Jan. 31, 2017	Oct. 26, 2016	Oct. 26, 2016	Sep. 30, 2016	Jan. 21, 2017	Oct. 31, 2015	Jan. 31, 2017	Jan. 31, 2016	Apr. 30, 2016	Apr. 14, 2016
Debt conversion amount																												$ 15,000								$ 15,000	$ 15,000
Notes principal balance												$ 505,000													$ 550,000									$ 505,000	$ 550,000	$ 550,000				$ 505,000
Percentage of conversion price												70.00%																						70.00%						70.00%
Excercise Price																									$ 0.15	$ 0.17	$ 0.18	$ 0.18							$ 0.15	$ 0.15	$ 0.17
Notes payable, related parties												$ 15,300																						$ 15,300						$ 15,300		$ 20,300
Repayment of notes payable to related parties																																							$ 15,000	5,000	$ 15,000
Repayment of notes payable																																								25,000
Notes payable												300,000																						300,000						300,000		100,000
Advances												$ 61,000																						$ 61,000						61,000
Number of shares of stock under private placement																																		610,000
Warrants exercised																														100,000				305,000
Proceeds from the offering under private placement																																		$ 61,000
Proceeds allocated to shares of stock																																		61,000						$ 61,000	$ 469,450	554,450
Proceeds allocated to warrants																																		$ 5,194
August 4, 2016 Promissory Note [Member]
Debt instrument, interest rate												8.00%																						8.00%						8.00%
Debt instrument, face amount												$ 130,000																						$ 130,000						$ 130,000
Repayment of notes payable													$ 25,000
Notes payable												$ 105,000																						$ 105,000						$ 105,000
Convertible Debt [Member]
Debt instrument, conversion price (dollars per share)																																							$ 0.30
Stock price																																											$ 0.50
Excercise Price																																											$ 0.30
Convertible Debt [Member] | Secured Promissory Note Dated March 9 [Member]
Number of trading days																													20 days
Debt instrument, conversion price (dollars per share)														$ 0.12	$ 0.08	$ 0.10	$ 0.10	$ 0.12	$ 0.13	$ 0.17	$ 0.14	$ 0.17	$ 0.21		0.15	0.17	0.18	0.18							0.15	0.15	0.17
Fair value of warrant																													$ 239,069
Stock price												$ 0.14		0.12	0.08	0.10	0.10	0.12	0.13	0.17	0.14	0.17	0.21	$ 0.20	0.22	0.24	0.29	0.29						$ 0.14	0.22	0.22	0.24			$ 0.14
Excercise Price												$ 0.05		$ 0.05	$ 0.06	$ 0.07	$ 0.07	$ 0.08	$ 0.09	$ 0.09	$ 0.10	$ 0.12	$ 0.14	$ 0.14	$ 0.15	$ 0.17	$ 0.18	$ 0.18						$ 0.05	$ 0.15	$ 0.15	$ 0.17			$ 0.05
Expected term												1 month 6 days		1 month 13 days	1 month 13 days	1 month 24 days	2 months 1 day	2 months 9 days	2 months 16 days	2 months 23 days	2 months 27 days	3 months 22 days	4 months 6 days	4 months 6 days	4 months 13 days	5 months 9 days	5 months 23 days		1 year
Expected volatility												181.00%		179.00%	179.00%	173.00%	174.00%	176.00%	176.00%	175.00%	175.00%	177.00%	175.00%	175.00%	179.00%	175.00%	181.00%		247.00%
Discount rate												0.52%		0.50%	0.51%	0.51%	0.52%	0.46%	0.51%	0.50%	0.54%	0.50%	0.36%	0.20%	0.25%	0.20%	0.25%		0.03%
Reclassification of embedded conversion option liability to additional paid in capital																																			$ 38,540			$ 112,824
Subsequent Event [Member]
Notes payable, related parties		$ 4,300																														$ 4,300
Repayment of notes payable to related parties											$ 11,000
Number of shares of stock under private placement						610,000
Warrants exercised						305,000																											467,500
Proceeds from the offering under private placement						$ 61,000																											$ 93,500
Proceeds allocated to shares of stock						55,996																											84,460
Proceeds allocated to warrants						$ 5,034																											$ 9,040
Shares of stock issued in private placement																																	935,000
Subsequent Event [Member] | August 4, 2016 Promissory Note [Member]
Repayment of notes payable			$ 25,000		$ 20,000		$ 25,000
Notes payable		35,000																														35,000
Subsequent Event [Member] | Convertible Debt [Member] | Secured Promissory Note Dated March 9 [Member]
Debt conversion amount	$ 15,000	15,000		$ 15,000	$ 15,000		$ 20,000	$ 30,000	$ 15,000	$ 15,000	$ 15,000
Number of trading days																															20 days
Shares issued upon conversion of debt																															2,722,098
Notes principal balance	$ 200,000	$ 215,000																													$ 200,000	$ 215,000
Percentage of conversion price	70.00%																														70.00%
Debt instrument, conversion price (dollars per share)	$ 0.05	$ 0.06		$ 0.06	$ 0.06		$ 0.05	$ 0.05	$ 0.05	$ 0.05	$ 0.05																				$ 0.05	$ 0.06	$ 0.06
Debt instrument, maturity date																																Jun. 9, 2017
Number of shares issuable under forbearance agreement		500,000																														500,000
Legal fees payable under forbearance agreement		$ 2,000																														$ 2,000
Term of warrant																																3 years
Number of warrants issuable under forbearance agreement		500,000																														500,000
Exercise price of warrants		$ 0.10																														$ 0.10
Debt instrument, interest rate		22.00%																														22.00%
Fair value of warrant																																$ 215,000
Debt discount		$ 28,015																														$ 28,015
Stock price		$ 0.08																														$ 0.08
Excercise Price		$ 0.10																														$ 0.10
Expected term																																3 years
Expected volatility																																173.00%
Discount rate																																0.75%
Reclassification of embedded conversion option liability to additional paid in capital																																$ 40,000
Subsequent Event [Member] | Convertible Debt [Member] | Secured Promissory Note Dated March 9 [Member] | Common Stock [Member]
Debt discount		$ 29,331																														$ 29,331